false
0001766478
0001766478
2024-07-18
2024-07-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of earliest event reported):
July 18, 2024
Angel
Oak Mortgage REIT, Inc.
(Exact name of registrant as specified in its
charter)
Maryland |
001-40495 |
37-1892154 |
(State
or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS
Employer
Identification No.) |
3344 Peachtree Road Northeast, Suite 1725, Atlanta, Georgia 30326
(Address of Principal Executive Offices and Zip
Code)
(404)
953-4900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange
on which registered |
Common
stock, $0.01 par value per share |
|
AOMR |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
On July 18, 2024, Angel
Oak Mortgage REIT, Inc., a Maryland corporation (the “Company”), Angel Oak Mortgage Operating Partnership, LP, a Delaware
limited partnership (the “Guarantor”), and Falcons I, LLC, a Delaware limited liability company and the Company’s external
manager (the “Manager”), entered into an underwriting agreement (the “Underwriting Agreement”) with RBC Capital
Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC and Piper Sandler & Co., as representatives of the several underwriters
named therein, with respect to the underwritten public offering of $50.0 million aggregate principal amount of the Company’s 9.500%
Senior Notes due 2029 (the “Notes”), which will be fully and unconditionally guaranteed by the Guarantor. A copy of the Underwriting
Agreement is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Notes will be issued pursuant
to an indenture (the “Base Indenture”) by and among the Company, the Guarantor and U.S. Bank Trust Company, National Association,
as trustee (the “Trustee”), as supplemented by a first supplemental indenture (the “Supplemental Indenture”),
by and among the Company, the Guarantor and the Trustee, each to be dated as of July 25, 2024. The Base Indenture and the Supplemental
Indenture will be filed with the Securities and Exchange Commission (the “Commission”) on a subsequent Current Report on Form 8-K.
The Notes are being offered
pursuant to an effective shelf registration statement filed with the Commission on June 27, 2024 (Registration Nos. 333-280531 and
333-280531-01), which was declared effective by the Commission on July 9, 2024, a base prospectus, dated July 9, 2024, and a
prospectus supplement, dated July 18, 2024, filed with the Commission pursuant to Rule 424(b) under the Securities Act
of 1933, as amended.
The Company estimates that
the net proceeds from the offering will be approximately $47.7 million, after deducting the underwriting discount and estimated offering
expenses payable by the Company. The Company intends to use the majority of the net proceeds from the offering for general corporate purposes,
which may include the acquisition of non-qualified residential mortgage loans and other target assets primarily sourced from its affiliated
proprietary mortgage lending platform or other target assets through the secondary market in a manner consistent with the Company’s
strategy and investment guidelines. Additionally, the Company intends to use the net proceeds from the offering to repurchase approximately
1,707,922 shares of the Company’s common stock owned by Xylem Finance LLC, an affiliate of Davidson Kempner Capital Management LP,
for an aggregate repurchase price of approximately $20.0 million.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit No. |
Description |
Exhibit 1.1 |
Underwriting Agreement, dated July 18, 2024, among Angel Oak Mortgage REIT, Inc., Angel Oak Mortgage Partnership, LP and Falcons I, LLC, on the one hand, and RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC and Piper Sandler & Co., as representatives of the several Underwriters named therein, on the other hand |
|
|
Exhibit 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 24, 2024 |
ANGEL OAK MORTGAGE REIT, INC. |
|
|
|
|
By: |
/s/ Brandon Filson |
|
Name: |
Brandon Filson |
|
Title: |
Chief Financial Officer and Treasurer |
Exhibit 1.1
EXECUTION
VERSION
|
ANGEL
OAK MORTGAGE REIT, INC.
$50,000,000
9.500% Senior notes due 2029
UNDERWRITING
AGREEMENT
Dated: JULY 18, 2024 |
|
|
Table
Of Contents
|
|
|
Page |
|
|
|
|
SECTION 1. |
|
Representations and Warranties |
3 |
|
|
|
|
SECTION 2. |
|
Sale and Delivery to Underwriters; Closing |
23 |
|
|
|
|
SECTION 3. |
|
Covenants of the Transaction Entities |
24 |
|
|
|
|
SECTION 4. |
|
Covenants of the Manager |
28 |
|
|
|
|
SECTION 5. |
|
Payment of Expenses |
28 |
|
|
|
|
SECTION 6. |
|
Conditions of Underwriters’ Obligations |
29 |
|
|
|
|
SECTION 7. |
|
Indemnification |
32 |
|
|
|
|
SECTION 8. |
|
Contribution |
34 |
|
|
|
|
SECTION 9. |
|
Representations, Warranties and Agreements to Survive
Delivery |
35 |
|
|
|
|
SECTION 10. |
|
Termination of Agreement |
36 |
|
|
|
|
SECTION 11. |
|
Default by One or More of the Underwriters |
36 |
|
|
|
|
SECTION 12. |
|
Notices |
37 |
|
|
|
|
SECTION 13. |
|
Recognition of the U.S. Special Resolution Regimes |
37 |
|
|
|
|
SECTION 14. |
|
Parties |
38 |
|
|
|
|
SECTION 15. |
|
GOVERNING LAW AND TIME |
38 |
|
|
|
|
SECTION 16. |
|
Effect of Headings; Counterparts |
38 |
|
|
|
|
SECTION 17. |
|
Definitions |
38 |
|
|
|
|
SECTION 18. |
|
Permitted Free Writing Prospectuses |
43 |
|
|
|
|
SECTION 19. |
|
Absence of Fiduciary Relationship |
43 |
|
|
|
|
SECTION 20. |
|
Research Analyst Independence |
44 |
|
|
|
|
SECTION 21. |
|
Trial By Jury |
44 |
Exhibit A |
– |
Underwriters |
Exhibit B |
– |
Subsidiaries
of the Company |
Exhibit C |
– |
Pricing
Term Sheet |
Exhibit D-1 |
– |
Form of
Opinion of Company Counsel |
Exhibit D-2 |
– |
Form of
Opinion of Company Counsel |
Exhibit E |
– |
Form of
Opinion of Maryland Counsel |
Exhibit F |
– |
Issuer
General Use Free Writing Prospectuses |
ANGEL OAK MORTGAGE REIT, INC.
$50,000,000 9.500% Senior Notes due 2029
UNDERWRITING AGREEMENT
July 18, 2024
RBC Capital Markets, LLC
UBS Securities LLC
Wells Fargo Securities, LLC
Piper Sandler & Co.
As Representatives of the several Underwriters
c/o RBC Capital Markets, LLC
Brookfield Place
200 Vesey Street, 8th Floor
New York, New York 10281
c/o UBS Securities LLC
1285 Avenue of the Americas
New York, New York 10019
c/o Wells Fargo Securities, LLC
550 South Tryon Street, 5th Floor
Charlotte, North Carolina 28202
c/o Piper Sandler & Co.
1251 Avenue of the Americas, 6th Floor
New York, New York 10020
Ladies and Gentlemen:
Angel
Oak Mortgage REIT, Inc., a Maryland corporation (the “Company”), Angel Oak Mortgage Operating Partnership, LP,
a Delaware limited partnership (the “Operating Partnership,” and together with the Company, the “Transaction
Entities”), and Falcons I, LLC, a Delaware limited liability company (the “Manager”), confirm their respective
agreements with RBC Capital Markets, LLC (“RBC Capital Markets”), UBS Securities LLC (“UBS Investment Bank”),
Wells Fargo Securities, LLC (“Wells Fargo Securities”) and Piper Sandler & Co. (“Piper Sandler”)
and each of the other Underwriters named in Exhibit A hereto (collectively, the “Underwriters,” which term shall
also include any underwriter substituted as hereinafter provided in Section 11 hereof), for whom RBC Capital Markets, UBS Investment
Bank, Wells Fargo Securities and Piper Sandler are acting as representatives (in such capacity, the “Representatives”),
with respect to the issue and sale by the Company of a total of $50,000,000 aggregate principal amount of the Company’s
9.500% Senior Notes due 2029 (the “Notes”), which will be fully and unconditionally guaranteed as to the payment of
principal, premium and interest by the Operating Partnership (the “Guarantee”, and such Notes together with the corresponding
Guarantee thereof, the “Securities”).
The
Securities will be issued pursuant to that certain indenture (the “Base Indenture”) to be dated on or about July 25,
2024 among the Transaction Entities and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
The term “Indenture” as used herein includes the Base Indenture and the First Supplemental Indenture to be dated on
or about July 25, 2024, among the Transaction Entities and the Trustee (the “First Supplemental Indenture”),
establishing the form and terms of the Securities. To the extent there are no additional Underwriters named in Exhibit A hereto
other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters
shall mean either the singular or plural as the context requires. Certain terms used in this Agreement are defined in Section 17
hereof.
The Transaction Entities
understand that the Underwriters propose to make a public offering of the Securities as soon as the Representatives deem advisable after
this Agreement has been executed and delivered.
The Transaction Entities
have jointly prepared and filed with the Commission the Registration Statement, including the Base Prospectus, for registration under
the 1933 Act of the offering and sale of the Securities. The Company has filed with the Commission, as part of an amendment to the Registration
Statement or pursuant to Rule 424(b), one or more preliminary prospectuses to the Base Prospectus relating to the Securities which
is used together with the Base Prospectus, each of which has previously been furnished to you. Any reference herein to the Registration
Statement, a preliminary prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated or deemed to
be incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the 1933 Act on or before the Applicable
Time or the issue date of such preliminary prospectus or the Prospectus, as the case may be; and any reference herein to the terms “amend,”
“amendment” or “supplement” with respect to the Registration Statement, a preliminary prospectus or the Prospectus
shall be deemed to refer to and include the filing of any document under the 1933 Act after the Applicable Time or the date of such preliminary
prospectus or the Prospectus, as the case may be, deemed to be incorporated therein by reference. Promptly after the execution and delivery
of this Agreement, the Company will prepare and file the Prospectus Supplement with the Commission in accordance with the provisions
of Rule 430B and Rule 424(b), and the Company has previously advised you of all information (financial and other) that will
be set forth therein.
SECTION 1. Representations
and Warranties.
(a) Representations
and Warranties by the Transaction Entities. Each of the Transaction Entities, jointly and severally, represents and warrants to each
Underwriter as of the Applicable Time and as of the Closing Date referred to in Section 2(b) hereof, and agrees with each Underwriter,
as follows:
(1) Compliance
with Registration Requirements. The Company meets the requirements for use of Form S-3 under the 1933 Act and the Securities
have been duly registered under the 1933 Act pursuant to the Registration Statement. Each of the Registration Statement and any post-effective
amendments thereto have been declared effective under the 1933 Act and no stop order suspending the effectiveness of the Registration
Statement has been issued under the 1933 Act and no proceedings for that purpose have been instituted or are pending or, to the knowledge
of the Company, are contemplated by the Commission, and any request on the part of the Commission for additional information has been
complied with. The Registration Statement was initially filed with the Commission on June 27, 2024 and declared effective by the
Commission on July 9, 2024.
(2) Registration
Statement, Prospectus and Disclosure at Time of Sale. At the respective times that the Registration Statement and any amendments
to any of the foregoing were declared or became effective, as the case may be, each deemed effective date with respect to the Underwriters
pursuant to Rule 430B(f)(2) under the 1933 Act, and at the Closing Date, the Registration Statement and any amendments to any
of the foregoing complied and will comply in all material respects with the requirements of the 1933 Act, the 1933 Act Regulations and
the 1939 Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading.
At the respective
times the Prospectus or any amendment or supplement thereto was filed pursuant to Rule 424(b), at the Closing Date, and at any time
when a prospectus is required (or, but for the provisions of Rule 172, would be required) by applicable law to be delivered in connection
with sales of Securities (whether to meet the requests of purchasers pursuant to Rule 173(d) or otherwise), neither the Prospectus
nor any amendments or supplements thereto included or will include an untrue statement of a material fact or omitted or will omit to
state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.
As of the Applicable
Time (except in the case of clause (y) below) and as of each time prior to the Closing Date that an investor agrees (orally or in
writing) to purchase or, if applicable, reconfirms (orally or in writing) an agreement to purchase any Securities from the Underwriters,
neither (w) any Issuer General Use Free Writing Prospectuses, if any, issued at or prior to the Applicable Time, the Pre-Pricing
Prospectus as of the Applicable Time and the Pricing Term Sheet included on Exhibit C hereto, all considered together (collectively,
the “General Disclosure Package”), nor (x) any individual Issuer Limited Use Free Writing Prospectus, when considered
together with the General Disclosure Package, nor (y) any Issuer General Use Free Writing Prospectus issued subsequent to the Applicable
Time, when considered together with the General Disclosure Package, included or will include an untrue statement of a material fact or
omitted or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading.
The Pre-Pricing
Prospectus and the Prospectus and any amendments or supplements to any of the foregoing filed as part of the Registration Statement or
any amendment thereto, or filed pursuant to Rule 424 under the 1933 Act, or delivered to the Underwriters for use in connection
with the offering of the Securities, complied when so filed or when so delivered, as the case may be, in all material respects with the
1933 Act and the 1933 Act Regulations.
The representations
and warranties in the preceding paragraphs of this Section 1(a)(2) do not apply to (i) the part of the Registration Statement
which constitutes the Statement of Eligibility and Qualification on Form T-1 of the Trustee under the Trust Indenture Act, as amended,
or (ii) statements in or omissions from the Registration Statement, any preliminary prospectus, the Prospectus or any Issuer Free
Writing Prospectus or any amendment or supplement to any of the foregoing made in reliance upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives expressly for use therein, it being understood and agreed that
the only such information furnished by the Underwriters as aforesaid consists of the information described as such in Section 7(b) hereof.
At
the respective times that the Registration Statement or any amendment to any of the foregoing were filed and as of the earliest
time after the filing of the Registration Statement that the Company or any other offering participant made a bona fide offer of the
Securities within the meaning of Rule 164(h)(2) under the 1933 Act, and at the date hereof, the Company was not, is not and
will not be, as applicable, an “ineligible issuer” as defined in Rule 405, in each case without taking into account
any determination made by the Commission pursuant to paragraph (2) of the definition of such term in Rule 405; and, without
limitation to the foregoing, the Company has at all relevant times met, meets and will at all relevant times meet the requirements of
Rule 164 for the use of a free writing prospectus (as defined in Rule 405) in connection with the offering contemplated hereby.
The copies of the
Registration Statement and any amendments to any of the foregoing and the copies of each preliminary prospectus, each Issuer Free Writing
Prospectus that is required to be filed with the Commission pursuant to Rule 433 and the Prospectus and any amendments or supplements
to any of the foregoing, that have been or subsequently are delivered to the Underwriters in connection with the offering of the Securities
(whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise) were and will be identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T. For purposes
of this Agreement, references to the “delivery” or “furnishing” of any of the foregoing documents to the Underwriters,
and any similar terms, include, without limitation, electronic delivery.
Each Issuer Free
Writing Prospectus (if any), as of its issue date and at all subsequent times through the completion of the public offering and sale
of the Securities, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information
contained in the Registration Statement, any preliminary prospectus or the Prospectus that has not been superseded or modified.
(3) Incorporated
Documents. The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Pre-Pricing Prospectus
and the Prospectus, at the respective times they were or hereafter are filed with the Commission, complied and will comply in all material
respects with the requirements of the 1934 Act and the 1934 Act Regulations, as applicable, and did not and will not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading.
(4) Independent
Accountants. KPMG LLP, who certified the financial statements and any supporting schedules included or incorporated by reference
in the Registration Statement, the General Disclosure Package and the Prospectus, are independent public accountants as required by the
1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations and the PCAOB.
(5) Financial
Statements. The financial statements of the Company included or incorporated by reference in the Registration Statement, the General
Disclosure Package and the Prospectus, together with the related schedules (if any) and notes, present fairly in all material respects
the financial position of the Company and its consolidated subsidiaries at the dates indicated and the results of operations, changes
in stockholders’ equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; and all such
financial statements have been prepared in conformity with GAAP applied on a consistent basis throughout the periods involved and comply
in all material respects with all applicable accounting requirements under the 1933 Act and the 1933 Act Regulations or the 1934 Act
and the 1934 Act Regulations, as applicable. The supporting schedules, if any, included in the Registration Statement present fairly,
in accordance with GAAP, the information required to be stated therein in all material respects. All “non-GAAP financial measures”
(as such term is defined in the rules and regulations of the Commission), if any, contained in the Registration Statement, the General
Disclosure Package and the Prospectus comply with Regulation G of the 1934 Act and Item 10 of Regulation S-K of the Commission, to the
extent applicable.
(6) No
Material Adverse Change in Business. Except as otherwise disclosed therein, since the respective dates as of which information is
given in the Registration Statement, the General Disclosure Package and the Prospectus (in each case exclusive of any amendments or supplements
thereto subsequent to the date of this Agreement), (A) there has been no material adverse change or any development that could reasonably
be expected to result in a material adverse change in the condition (financial or other), results of operations, business, properties,
management or prospects of the Transaction Entities and their respective subsidiaries taken as a whole, whether or not arising in the
ordinary course of business (in any such case, a “Material Adverse Effect”); (B) neither of the Transaction Entities
nor any of their respective subsidiaries has incurred any liability or obligation or entered into any transaction or agreement that,
individually or in the aggregate, is material with respect to the Transaction Entities and their respective subsidiaries, taken as a
whole, and neither of the Transaction Entities nor any of their respective subsidiaries has sustained any loss or interference with its
business or operations from fire, explosion, flood, earthquake or other natural disaster or calamity, whether or not covered by insurance,
or from any labor dispute or disturbance or court or governmental action, order or decree which could reasonably be expected, individually
or in the aggregate, to result in a Material Adverse Effect; and (C) there has been no dividend or distribution of any kind declared,
paid or made by either of the Transaction Entities on any class of its capital stock or, in the case of the Operating Partnership, OP
Units.
(7) Good
Standing of the Company. The Company (i) has been duly organized and is validly existing as a corporation in good standing under
the laws of the State of Maryland and (ii) has power and authority to own, lease and operate its properties and to conduct its business
as described in the Registration Statement, the General Disclosure Package and the Prospectus and to enter into and perform its obligations
under this Agreement, the Indenture, and the Notes and (iii) is duly qualified as a foreign corporation to transact business and
is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except in the cases of clause (iii), where the failure to be so qualified or in good standing would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(8) Good
Standing of the Operating Partnership. The Operating Partnership (i) has been duly organized and is validly existing as a limited
partnership in good standing under the laws of the State of Delaware and (ii) has power and authority to own, lease and operate
its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus
and to enter into and perform its obligations under this Agreement, the Indenture, and the Guarantee and (iii) is duly qualified
as a foreign limited partnership to transact business and is in good standing in each jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of business, except in the cases of clause (iii), where the
failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. Angel Oak Mortgage OP GP, LLC (the “General Partner”), is the sole general partner of the Operating
Partnership.
(9) Good
Standing of Subsidiaries. Each subsidiary of the Company other than the Operating Partnership (i) has been duly organized and
is validly existing as a corporation, limited or general partnership or limited liability company, as the case may be, in good standing
under the laws of the jurisdiction of its organization, (ii) has power and authority to own, lease and operate its properties and
to conduct its business as described in the Registration Statement, the General Disclosure Package or the Prospectus and (iii) is
duly qualified as a foreign corporation, limited or general partnership or limited liability company, as the case may be, to transact
business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or
leasing of property or the conduct of business, except in the cases of clause (iii), where the failure to be so qualified or in good
standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; except as otherwise disclosed
in the Registration Statement, the General Disclosure Package and the Prospectus, all of the issued and outstanding shares of capital
stock of each subsidiary of the Company that is a corporation, all of the issued and outstanding partnership interests of each subsidiary
of the Company (including the Operating Partnership) that is a limited or general partnership and all of the issued and outstanding limited
liability company interests, membership interests or other similar interests of each such subsidiary that is a limited liability company
have been duly authorized and validly issued, are fully paid and (except in the case of general partnership interests) non-assessable
and are owned by the Company, directly or through subsidiaries, free and clear of any Lien; and none of the issued and outstanding shares
of capital stock of any such subsidiary that is a corporation, none of the issued and outstanding partnership interests of any such subsidiary
that is a limited or general partnership, and none of the issued and outstanding limited liability company interests, membership interests
or other similar interests of any such subsidiary that is a limited liability company was issued in violation of any preemptive rights,
rights of first refusal or other similar rights of any securityholder of such subsidiary or any other person. The only subsidiaries of
the Company are the subsidiaries listed on Exhibit B hereto and Exhibit B accurately sets forth whether each such subsidiary
is a corporation, limited or general partnership or limited liability company and the jurisdiction of organization of each such subsidiary
and, in the case of any subsidiary which is a partnership or limited liability company, its general partners and managing members, respectively.
(10) Capitalization.
The Company has the capitalization described in the General Disclosure Package and the Prospectus. The shares of issued and outstanding
capital stock of the Company have been duly authorized and validly issued and are fully paid and non-assessable and were issued in compliance
with all applicable foreign, state and federal securities and “blue-sky” laws; and none of the outstanding shares of capital
stock of the Company was issued in violation of any preemptive rights, rights of first refusal or other similar rights of any securityholder
of the Company or any other person.
(11) Operating
Partnership Interests. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other
rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any OP Units or other ownership
interests of the Operating Partnership, other than those described in the Registration Statement, the General Disclosure Package and
the Prospectus. The aggregate ownership percentage of the Company and the General Partner of the OP Units is as set forth in the Registration
Statement, the General Disclosure Package and the Prospectus.
(12) Management
Agreement and Operating Partnership Agreement. The Management Agreement has been duly authorized, executed and delivered by each
of the Transaction Entities and constitutes a valid and binding agreement of the Transaction Entities, enforceable in accordance with
its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors’ rights generally and by general equitable principles. The Operating Partnership Agreement has been duly authorized,
executed and delivered by each of the Transaction Entities and constitutes a valid and binding agreement of the Transaction Entities,
enforceable in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors’ rights generally and by general equitable principles.
(13) Authorization
of Agreement. This Agreement has been duly authorized, executed and delivered by each of the Transaction Entities.
(14) Authorization
of Base Indenture. The Base Indenture has been duly authorized by the Transaction Entities and, at the Closing Date, the Base Indenture
will have been duly executed by the Transaction Entities and duly qualified under the Trust Indenture Act. Assuming due authorization,
execution and delivery by the Trustee, the Base Indenture constitutes a valid and binding agreement of the Transaction Entities, enforceable
against the Transaction Entities in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable principles
and except to the extent that the indemnification provisions of the Base Indenture may be limited by federal or state securities laws
and public policy considerations in respect thereof.
(15) Authorization
of Supplemental Indenture. The Supplemental Indenture has been duly authorized by the Transaction Entities and, at the Closing Date,
the Supplemental Indenture will have been duly executed by the Transaction Entities and duly qualified under the Trust Indenture Act
and, assuming due authorization, execution and delivery by the Trustee, will constitute a valid and binding agreement of the Transaction
Entities, enforceable against the Transaction Entities in accordance with its terms, except to the extent that enforceability may be
limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general
equitable principles and except to the extent that the indemnification provisions of the Supplemental Indenture may be limited by federal
or state securities laws and public policy considerations in respect thereof.
(16) Authorization
of Notes. The Notes have been duly authorized by the Company for sale to the Underwriters pursuant to this Agreement and, when executed
and delivered by the Company and authenticated by the Trustee pursuant to the provisions of the Indenture relating thereto, against payment
of the consideration set forth in this Agreement, will constitute valid and binding obligations of the Company, enforceable in accordance
with their terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar
laws affecting creditors’ rights generally and by general equitable principles, and will be in the form contemplated by, and entitled
to the benefits of, the Indenture.
(17) Authorization
of Guarantee. The Guarantee has been duly authorized by the Operating Partnership and, at the Closing Date, the notations of the
Guarantee endorsed on the Notes issued at the Closing Date will have been duly executed by the Operating Partnership and, when the Securities
are issued and delivered in the manner provided for in the Indenture, will constitute valid and legally binding obligations of the Operating
Partnership, enforceable against the Operating Partnership in accordance with their terms, except to the extent that enforceability may
be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general
equitable principles, and such notations of the Guarantee will be in the form contemplated by the Indenture.
(18) Description
of Indenture and Securities. The Indenture and the Securities conform in all material respects to the descriptions thereof contained
in the Registration Statement, the General Disclosure Package and the Prospectus.
(19) Absence
of Defaults and Conflicts. Neither of the Transaction Entities nor any of their respective subsidiaries is (i) in violation
of its Organizational Documents or (ii) in default in the performance or observance of any obligation, agreement, covenant or condition
contained in any Company Document, except for such defaults that would not, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect. The execution, delivery and performance of this Agreement, the Indenture, and the Securities
and the consummation of the transactions contemplated herein and in the Registration Statement, the General Disclosure Package and the
Prospectus (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described
in the Pre-Pricing Prospectus and the Prospectus under the caption “Use of Proceeds”) and compliance by each of the Transaction
Entities with its obligations under this Agreement, the Indenture, and the Securities do not and will not, whether with or without the
giving of notice or passage of time or both, conflict with or constitute a breach of, or default, Termination Event or Repayment Event
under, or result in the creation or imposition of any Lien upon any property or assets of either of the Transaction Entities or any of
their respective subsidiaries pursuant to, any Company Documents, except for such conflicts, breaches, defaults or Liens that would not,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, nor will such action result in any violation
of (i) the provisions of the Organizational Documents of either of the Transaction Entities or any of their respective subsidiaries
or (ii) except as would not reasonably be expected to result in a Material Adverse Effect, any applicable law, statute, rule, regulation,
judgment, order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over
either of the Transaction Entities or any of their respective subsidiaries or any of their respective assets, properties or operations.
(20) Absence
of Labor Dispute. No labor dispute with the employees of either of the Transaction Entities, any of their respective subsidiaries
or the Manager exists or, to the knowledge of the Transaction Entities, is imminent, and neither of the Transaction Entities is aware
of any existing or imminent labor disturbance by the employees of any of the principal suppliers, manufacturers, customers or contractors
of the Transaction Entities, any of their respective subsidiaries or the Manager which would reasonably be expected, individually or
in the aggregate, to result in a Material Adverse Effect.
(21) Absence
of Proceedings. There is no action, suit, proceeding, inquiry or investigation before or brought by any court or governmental agency
or body, domestic or foreign, now pending, or, to the knowledge of the Transaction Entities, threatened, against either of the Transaction
Entities or any of their respective subsidiaries which is required to be disclosed in the Registration Statement, the General Disclosure
Package or the Prospectus (other than as disclosed therein), or which might reasonably be expected, individually or in the aggregate,
to result in a Material Adverse Effect, or to materially and adversely affect the consummation of the transactions contemplated in this
Agreement, the Indenture, and the Securities or the performance by the Transaction Entities of their respective obligations under this
Agreement, the Indenture, and the Securities.
(22) Accuracy
of Descriptions and Exhibits. The information in the General Disclosure Package and the Prospectus under the captions “Risk
Factors—Risks Related to our Organizational Structure,” “Risk Factors—Risks Related to our REIT Qualification
and Certain Other U.S. Federal Income Tax Items,” “Risk Factors—Risks Related to Our Company—Maintenance of our
exclusion from regulation as an investment company under the Investment Company Act imposes significant limitations on our operations,”
“Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Description
of Existing Financing Arrangements,” “Certain Provisions of Maryland Law and of our Charter and Bylaws,” “Certain
Relationships and Related Party Transactions,” “Description of Stock,” “and “Material U.S. Federal Income
Tax Considerations,” and the information in the Registration Statement under Item 15, in each case to the extent that it constitutes
matters of law, summaries of legal matters, summaries of provisions of either of the Transaction Entities’ Organizational Documents
or any other instruments or agreements, summaries of legal proceedings, or legal conclusions, is correct in all material respects; all
descriptions in the Registration Statement, the General Disclosure Package and the Prospectus of any other Company Documents are accurate
in all material respects; and there are no franchises, contracts, indentures, mortgages, deeds of trust, loan or credit agreements, bonds,
notes, debentures, evidences of indebtedness, leases or other instruments, agreements or documents required to be described or referred
to in the Registration Statement, the General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement
which have not been so described and filed as required.
(23) Possession
of Intellectual Property. Except as would not reasonably be expected to have, singly or in the aggregate, a Material Adverse Effect,
(i) the Transaction Entities and their respective subsidiaries own and possess or have valid and enforceable licenses to use, all
patents, patent rights, patent applications, licenses, copyrights, inventions, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), trade marks, service marks, trade names, service
names, software, internet addresses, domain names and other intellectual property (collectively, “Intellectual Property”)
that is described in the Registration Statement, the General Disclosure Package or the Prospectus or that is necessary for the conduct
of their respective businesses as currently conducted and as described in the Registration Statement, the General Disclosure Package
and the Prospectus; (ii) neither of the Transaction Entities nor any of their respective subsidiaries has received any notice or
is otherwise aware of any infringement of or conflict with rights of others with respect to any Intellectual Property; (iii) there
are no third parties who have or, to the knowledge of the Transaction Entities, will be able to establish rights to any Intellectual
Property of the Transaction Entities or any of their respective subsidiaries, except for, and to the extent of, the ownership rights
of the owners of the Intellectual Property which the Registration Statement, the General Disclosure Package and the Prospectus disclose
is licensed to the Transaction Entities or any of their respective subsidiaries; (iv) there is no pending or, to the knowledge of
the Transaction Entities, threatened action, suit, proceeding or claim by others challenging the Transaction Entities’ or any of
their respective subsidiaries’ rights in or to any such Intellectual Property, or challenging the validity, enforceability or scope
of any such Intellectual Property, or asserting that either of the Transaction Entities or any of their respective subsidiaries infringes
or otherwise violates, or would, upon the commercialization of any product or service described in the Registration Statement, the General
Disclosure Package or the Prospectus, infringe or violate, any Intellectual Property of others, and the Transaction Entities are unaware
of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; and (v) the Transaction Entities
and their respective subsidiaries have complied with the terms of each agreement pursuant to which any Intellectual Property has been
licensed to the Transaction Entities or any of their respective subsidiaries, all such agreements are in full force and effect, and the
Transaction Entities are unaware of any event or condition that has occurred or exists that gives or, with notice or passage of time
or both, would give any person the right to terminate any such agreement.
(24) Absence
of Further Requirements. (A) No filing with, or authorization, approval, consent, license, order, registration, qualification
or decree of, any court or governmental authority or agency, domestic or foreign, (B) no authorization, approval, waiver or consent
under any Company Document, and (C) no authorization, approval, vote or consent of any other person or entity, is necessary or required
for the authorization, execution, delivery or performance by the Transaction Entities of this Agreement, the Indenture, and the Securities,
for the offering of the Securities as contemplated by this Agreement, for the issuance, sale or delivery of the Securities to be sold
by the Transaction Entities pursuant to this Agreement or for the consummation of any of the other transactions contemplated by this
Agreement, the Indenture, and the Securities, in each case on the terms contemplated by the Registration Statement, the General Disclosure
Package and the Prospectus, except such as have been obtained under the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934
Act Regulations and except that no representation is made as to such as may be required under state or foreign securities laws.
(25) Possession
of Licenses and Permits. The Transaction Entities and their respective subsidiaries possess such permits, licenses, approvals, consents
and other authorizations (collectively, “Governmental Licenses”) issued by the appropriate federal, state, local or
foreign regulatory agencies or bodies necessary to conduct the business now operated by them; and, except as would not, individually
or in the aggregate, result in a Material Adverse Effect, neither of the Transaction Entities nor any of their respective subsidiaries
has received any notice of proceedings relating to the revocation or modification of any such Governmental Licenses.
(26) Title
to Property. The Transaction Entities and their respective subsidiaries have good and marketable title to all real property owned
by any of them (if any) and good title to all other properties and assets owned by any of them, in each case, free and clear of all Liens
except such as (a) are described in the Registration Statement, the General Disclosure Package and the Prospectus or (b) would
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; all real property, buildings and other
improvements, and all equipment and other property, held under lease or sublease by the Transaction Entities or any of their respective
subsidiaries is held by them under valid, subsisting and enforceable leases or subleases, as the case may be, with such exceptions as
would not reasonably be expected to have a Material Adverse Effect; and neither of the Transaction Entities nor any of their respective
subsidiaries has received any notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Transaction
Entities or any of their respective subsidiaries under any of the leases or subleases mentioned above or affecting or questioning the
rights of the Transaction Entities or any of their respective subsidiaries to the continued possession of the leased or subleased premises,
or to the continued use of the leased or subleased equipment or other property, except for such claims which, if successfully asserted
against the Transaction Entities or any of their respective subsidiaries, would not, individually or in the aggregate, result in a Material
Adverse Effect.
(27) Investment
Company Act. Neither of the Transaction Entities nor any of their respective subsidiaries are, and upon the issuance and sale of
the Securities as herein contemplated and the receipt and application of the net proceeds therefrom as described in the General Disclosure
Package and the Prospectus under the caption “Use of Proceeds,” will be, an “investment company” or an entity
“controlled” by an “investment company” as such terms are defined in the 1940 Act.
(28) Environmental
Laws. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus and except as would not,
individually or in the aggregate, result in a Material Adverse Effect, (A) neither of the Transaction Entities nor any of their
respective subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy
or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order,
consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient
air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations
relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances,
petroleum or petroleum products (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”),
(B) the Transaction Entities and their respective subsidiaries have all permits, authorizations and approvals required under any
applicable Environmental Laws to conduct the business now operated by them and are each in compliance with their requirements, (C) there
are no pending or, to the knowledge of either Transaction Entity, threatened administrative, regulatory or judicial actions, suits, demands,
demand letters, claims, Liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law
against the Transaction Entities or any of their respective subsidiaries and (D) to the knowledge of the Transaction Entities, there
are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up or remediation, or an action,
suit or proceeding by any private party or governmental body or agency, against or affecting the Transaction Entities or any of their
respective subsidiaries relating to Hazardous Materials or any Environmental Laws.
(29) Absence
of Registration Rights. There are no persons with (A) registration rights or other similar rights to have any securities (debt
or equity) registered pursuant to the Registration Statement or included in the offering contemplated by this Agreement or (B) co-sale
rights, tag-along rights or other similar rights to have any securities (debt or equity) included in the offering contemplated by this
Agreement or sold in connection with the sale of Securities, except in each case for any such rights that have been duly waived in writing;
and the Company has given all notices required by, and has otherwise complied with its obligations under, all registration rights agreements,
co-sale agreements, tag-along agreements and other similar agreements in connection with the transactions contemplated by this Agreement.
(30) Tax
Returns. The Transaction Entities and their respective subsidiaries have filed all foreign, federal, state and local tax returns
that are required to be filed or have obtained extensions thereof, except where the failure to so file would not, individually or in
the aggregate, result in a Material Adverse Effect, and have paid all taxes (including, without limitation, any estimated taxes) required
to be paid to the extent that any of the foregoing is due and payable, except for any such tax that is currently being contested in good
faith and except for such taxes the nonpayment of which would not, individually or in the aggregate, result in a Material Adverse Effect.
(31) Insurance.
The Transaction Entities and their respective subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; the Transaction Entities
and their respective subsidiaries are in compliance with the terms of such policies and instruments in all material respects; there are
no claims by the Transaction Entities or any of their respective subsidiaries under any such policy or instrument as to which any insurance
company is denying liability or defending under a reservation of rights clause; and neither the Transaction Entities nor any such subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers at a cost that would not, individually or in the aggregate, reasonably be expected to result in
a Material Adverse Effect.
(32) Accounting
and Disclosure Controls. The Company and its subsidiaries maintain effective “internal control over financial reporting”
(as defined in Rule 13a-15 of the 1934 Act Regulations) and maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (A) transactions are executed in accordance with management’s general or specific authorizations;
(B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability; (C) access to assets is permitted only in accordance with management’s general or specific authorization;
(D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences; and (E) the interactive data in eXtensible Business Reporting Language included or incorporated
by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly represents the information called
for in all material respects and is prepared in accordance with the Commission’s rules and guidelines applicable thereto.
Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, since the incorporation of the
Company, there has been (1) no material weakness in the Company’s internal control over financial reporting (whether or not
remediated) and (2) no change in the Company’s internal control over financial reporting that has adversely affected, or is
reasonably likely to adversely affect, the Company’s internal control over financial reporting. The Company and each of its subsidiaries
maintain an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the 1934
Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or
submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s
rules and forms, and is accumulated and communicated to the Company’s management, including its principal executive officer
or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure.
The Company’s
independent public accountants and the audit committee of the Company’s board of directors have been advised of: (i) all material
weaknesses, if any, and significant deficiencies (as defined in Rule 1-02 of Regulation S-X of the Commission), if any, in the Company’s
internal control over financial reporting that have adversely affected, or are reasonably likely to adversely affect, the ability of
the Company and its subsidiaries to record, process, summarize and report financial information; and (ii) any fraud, whether or
not material, involving management or other employees who have a significant role in the Company’s internal control over financial
reporting.
(33) Compliance
with the Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or any of the Company’s directors
or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act with which any of them is required to
comply, including Section 402 related to loans and Sections 302 and 906 related to certifications.
(34) Pending
Proceedings and Examinations; Comment Letters. The Registration Statement is not the subject of a pending proceeding or examination
under Section 8(d) or 8(e) of the 1933 Act, and the Company is not the subject of a pending proceeding under Section 8A
of the 1933 Act. The Company has provided the Representatives with true, complete and correct copies of any written comments received
from the Commission by the Company or its legal counsel or accountants with respect to the Registration Statement, any preliminary prospectus,
the Prospectus, any Issuer Free Writing Prospectus or any amendments or supplements to any of the foregoing and of all written responses
thereto, and no such comments remain unresolved.
(35) Absence
of Manipulation. Neither of the Transaction Entities has taken, nor will it take, directly or indirectly, any action designed to
or that would constitute or that might reasonably be expected to cause or result in the stabilization or manipulation of the price of
any security of the Company to facilitate the sale or resale of the Securities.
(36) Statistical
and Market-Related Data. Any statistical, demographic, market-related and similar data included in the Registration Statement, the
General Disclosure Package or the Prospectus are based on or derived from sources that the Company reasonably believes to be reliable
and accurate in all material respects and accurately reflect the materials upon which such data is based or from which it was derived.
(37) No
Unlawful Payments. Neither of the Transaction Entities nor any of their respective subsidiaries nor any director, officer or employee
of the Transaction Entities or any of their respective subsidiaries nor, to the knowledge of the Transaction Entities, any agent, affiliate
or other person associated with or acting on behalf of the Transaction Entities or any of their respective subsidiaries or affiliates
is aware of or has taken any action, directly or indirectly, that has resulted or would result in (i) the use of any funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) the making or taking of
an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic
government or regulatory official or employee, including of any government-owned or controlled entity or of a public international organization,
or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate
for political office; (iii) a violation by any such person of any provision of the Foreign Corrupt Practices Act of 1977, as amended,
or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International
Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery
or anti-corruption laws (collectively, the “Anti-Corruption Laws”); or (iv) the making, offering, requesting
or taking of, or the agreement to take, an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation,
any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Transaction Entities and their
respective subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures reasonably
designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. Neither of the Transaction Entities
nor their respective subsidiaries will use, directly or indirectly, the proceeds of the offering of Securities for the purpose of funding
or facilitating offering, paying, promising to pay or authorizing the payment or giving of money, or anything else of value, to any person
in violation of any applicable anti-corruption laws.
(38) Compliance
with Money Laundering Laws. The operations of each of the Transaction Entities and their respective subsidiaries are and have been
conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all applicable jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced
by any governmental or regulatory agency (collectively, the “Anti-Money Laundering Laws”) and no action, suit or proceeding
by or before any court or governmental or regulatory agency, authority or body or any arbitrator involving the Transaction Entities or
any of their respective subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Transaction
Entities, threatened against the Transaction Entities or any of their respective subsidiaries.
(39) No
Conflicts with Sanction Laws. Neither of the Transaction Entities nor any of their respective subsidiaries, directors, officers or
employees, nor, to the knowledge of the Transaction Entities, any agent, employee or affiliate or other person associated with or acting
on behalf of the Transaction Entities or any of their respective subsidiaries is, or is owned or controlled by one or more persons that
are, currently the subject or the target of any sanctions administered or enforced by the U.S. Government (including, without limitation,
OFAC or the U.S. Department of State and including, without limitation, the designation as a “specially designated national”
or “blocked person”), the United Nations Security Council, the European Union, His Majesty’s Treasury, or other relevant
sanctions authority (collectively, “Sanctions”), nor located, organized or resident in a country or territory that
is the subject or the target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea Region of Ukraine,
the so-called Donetsk People’s Republic and the so-called Luhansk People’s Republic regions of Ukraine, and the non-government
controlled areas of Kherson and Zaporizhzhia regions of Ukraine (each, a “Sanctioned Country”); and the Transaction
Entities will not directly or indirectly use any of the proceeds of the offering, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business
with any person that, at the time of such funding or facilitation, is the subject or the target of any Sanctions, (ii) to fund or
facilitate any activities of or any business in any Sanctioned Country or (iii) in any other manner that could result in a violation
by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of any
Sanctions. For the past ten years, the Transaction Entities and their respective subsidiaries have not knowingly engaged in, are not
now knowingly engaged in, and will not engage in, any dealings or transactions with any person that at the time of the dealing or transaction
is or was the subject or the target of any Sanctions or with any Sanctioned Country.
(40) ERISA
Compliance. None of the following events has occurred or exists: (i) a failure to fulfill the obligations, if any, under
the minimum funding standards of Section 302 of ERISA or Section 412 of the Internal Revenue Code of 1986, as amended (the
“Code”), with respect to a Plan (as defined below) determined without regard to any waiver of such obligations or
extension of any amortization period; (ii) an audit or investigation by the IRS, the U.S. Department of Labor, the U.S. Pension
Benefit Guaranty Corporation or any other federal, state or foreign governmental or regulatory agency with respect to the employment
or compensation of employees by the Company or any of its ERISA Affiliates (as defined below) that might reasonably be expected, individually
or in the aggregate, to result in a Material Adverse Effect; or (iii) any breach of any contractual obligation, or any violation
of law or applicable qualification standards, with respect to the employment or compensation of employees by the Company or any of its
ERISA Affiliates that might reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Each Plan
is and has been operated and administered in accordance with its terms and applicable law, and is in compliance in form with ERISA, the
Code (including, where intended to be qualified under Section 401(a) of the Code, such Plan has been determined by the IRS
to be so qualified or is in the process of being approved by the IRS) and all other applicable federal, state or local laws and regulations
save where any failure to comply could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
None of the following events has occurred or is reasonably likely to occur: (v) a material increase in the aggregate amount of contributions
required to be made to all Plans in the current fiscal year of the Company and its ERISA Affiliates compared to the amount of such contributions
made in the Company’s or the ERISA Affiliate’s most recently completed fiscal year; (w) a material increase in the “accumulated
post-retirement benefit obligations” (within the meaning of Financial Accounting Board Accounting Standards Codification Topic
715-60) of the Company and its subsidiaries compared to the amount of such obligations in the Company’s most recently completed
fiscal year; (x) any event or condition giving rise to any actual or contingent, direct or indirect liability under Title IV or
Section 302 of ERISA or Section 412 of the Code that might reasonably be expected, individually or in the aggregate, to result
in a Material Adverse Effect; (y) the filing of a claim by one or more employees or former employees of the Company or any of its
ERISA Affiliates related to its or their employment that might reasonably be expected, individually or in the aggregate, to result in
a Material Adverse Effect; or (z) one or more nonexempt prohibited transactions under Section 406 of ERISA or Section 4975
of the Code that might reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. For purposes
of this paragraph and the definition of ERISA, the term “Plan” means an “employee benefit plan” or “plan”
(within the meaning of Section 3(3) of ERISA or Section 4975(e)(1) of the Code) with respect to which the Company
or any of its ERISA Affiliates may have any actual or contingent, direct or indirect liability and the term “ERISA Affiliate”
means any person that would be deemed at any relevant time to be a single employer with the Company pursuant to Section 414(b),
(c), (m) or (o) of the Code or under common control with the Company under Section 4001 of ERISA.
(41) Lending
and Other Relationship. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus,
(i) neither of the Transaction Entities nor any of their respective subsidiaries has any material lending or similar relationship
with any Underwriter or any bank or other lending institution affiliated with any Underwriter; or (ii) the Transaction Entities
will not, directly or indirectly, use any of the proceeds from the sale of the Securities by the Company hereunder to reduce or retire
the balance of any loan or credit facility extended by any Underwriter or any of its “affiliates” or “associated persons”
(as such terms are used in FINRA Rule 5121) or otherwise direct any such proceeds to any Underwriter or any of its “affiliates”
or “associated persons” (as so defined).
(42) Related
Party Transactions. There are no business relationships or related party transactions involving the Transaction Entities or any of
their respective subsidiaries or, to the knowledge of the Transaction Entities, any other person that are required to be described in
the Registration Statement, the General Disclosure Package or the Prospectus that have not been described as required.
(43) Offering
Materials. Without limitation to the provisions of Section 18 hereof, the Company has not distributed and will not distribute,
directly or indirectly (other than through the Underwriters), any “written communication” (as defined Rule 405 under
the 1933 Act) or other offering materials in connection with the offering or sale of the Securities, other than the Pre-Pricing Prospectus,
the Prospectus, any amendment or supplements to any of the foregoing that are filed with the Commission and any Permitted Free Writing
Prospectuses (as defined in Section 18).
(44) No
Restrictions on Dividends. Neither of the Transaction Entities nor any of their respective subsidiaries is a party to or otherwise
bound by any instrument or agreement that limits or prohibits, directly or indirectly, the Company from paying any dividends or making
other distributions on its capital stock, and no subsidiary of the Company, including the Operating Partnership, is a party to or otherwise
bound by any instrument or agreement that limits or prohibits, directly or indirectly, any subsidiary, including the Operating Partnership,
of the Company from paying any dividends or making any other distributions on its capital stock, limited or general partnership interests,
limited liability company interests, or other equity interests, as the case may be, or from repaying any loans or advances from, or (except
for instruments or agreements that by their express terms prohibit the transfer or assignment thereof or of any rights thereunder) transferring
any of its properties or assets to, the Transaction Entities or any of their respective subsidiaries, in each case except as described
in the Registration Statement, the General Disclosure Package and the Prospectus or as would not reasonably be expected to result in
a Material Adverse Effect.
(45) Brokers.
There is not a broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s fee or other
fee or commission as a result of any of the transactions contemplated by this Agreement, except for underwriting discounts and commissions
payable to the Underwriters in connection with the sale of the Securities to the Underwriters pursuant to this Agreement.
(46) Real
Estate Investment Trust. Commencing with its taxable year ended December 31, 2019, the Company has been organized and has operated
in conformity with the requirements for qualification and taxation as a real estate investment trust (a “REIT”) under
the Code and all applicable regulations under the Code, and its form of organization and proposed method of operation will enable it
to continue to meet the requirements for qualification and taxation as a REIT under the Code and all applicable regulations under the
Code.
(47) Cybersecurity.
Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there has been no security breach
or incident, unauthorized access or disclosure, or other compromise of or relating to either of the Transaction Entities’ and their
respective subsidiaries’ information technology and computer systems, networks, hardware, software, data and databases (including
the data and information of their respective customers, employees, suppliers, vendors and any third party data maintained, processed
or stored by the Transaction Entities and their respective subsidiaries, and any such data processed or stored by third parties on behalf
of the Transaction Entities and their respective subsidiaries), equipment or technology (collectively, “IT Systems and Data”)
and the Transaction Entities and their respective subsidiaries have not been notified of, and have no knowledge of any event or condition
that would reasonably be expected to result in, any security breach or incident, unauthorized access or disclosure or other compromise
to their IT Systems and Data. The Transaction Entities and their respective subsidiaries are presently in material compliance with all
applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification. The Transaction Entities and their respective
subsidiaries have implemented controls, policies, procedures, and technological safeguards to maintain and protect the integrity, continuous
operation, redundancy and security of their IT Systems and Data reasonably consistent with industry standards and practices, or as required
by applicable regulatory standards.
(b) Representations
and Warranties of the Manager. The Manager represents and warrants to each Underwriter as of the date hereof, as of the Applicable
Time and as of the Closing Date referred to in Section 2(b) hereof:
(1) Organization
and Good Standing. The Manager (i) has been duly organized and is validly existing as a limited liability company in good standing
under the laws of the State of Delaware and (ii) has power and authority to own, lease and operate its properties and to conduct
its business as described in the Registration Statement, the General Disclosure Package and the Prospectus and to enter into and perform
its obligations under this Agreement and the Management Agreement and (iii) is duly qualified as a foreign limited liability company
to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership
or leasing of property or the conduct of business, except in cases of clause (iii), where the failure to be so qualified or in good standing
would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the condition (financial or
other), results of operations, business, properties, management or prospects of the Manager (a “Manager Material Adverse Effect”).
(2) Authorization
of Agreement. This Agreement has been duly authorized, executed and delivered by the Manager.
(3) Authorization
of the Management Agreement. The Management Agreement has been duly authorized, executed and delivered by the Manager, and constitutes
a valid and legally binding agreement of the Manager enforceable against the Manager in accordance with its terms, except as enforceability
may be limited by applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally or by equitable principles
relating to enforceability.
(4) Manager-Related
Disclosure. The information regarding the Manager and its affiliates (other than the Company and its subsidiaries) in the Registration
Statement, the General Disclosure Package or Prospectus is true and correct in all material respects. As of the date of this Agreement,
the Manager has no plan or intention to materially alter its investment policy or investment allocation policy with respect to the Company
as described in the Registration Statement, the General Disclosure Package and the Prospectus.
(5) Absence
of Defaults and Conflicts. The Manager is not (i) in violation of its Organizational Documents or (ii) in violation of
or in default under any existing obligation, agreement, covenant or condition contained in any indenture, loan agreement, mortgage, lease
or other agreement or instrument to which it is a party or by which it, or any of its properties, is bound, except in the case of clause
(ii) as would not, individually or in the aggregate, reasonably be expected to result in a Manager Material Adverse Effect. The
execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration
Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities and the use of the proceeds
from the sale of the Securities as described in the General Disclosure Package and the Prospectus under the caption “Use of Proceeds”)
and compliance by the Manager with its obligations under this Agreement and the Management Agreement do not and will not, whether with
or without the giving of notice or passage of time or both, conflict with or constitute a breach of or violation of, or constitute a
default under, or result in the creation or imposition of any Lien upon any property or assets of the Manager pursuant to, any contracts,
indentures, mortgages, deeds of trust, loan or credit agreements, bonds, notes, debentures, evidences of indebtedness, swap agreements,
hedging agreements, leases or other instruments or agreements to which the Manager is a party, except for such conflicts, breaches, defaults
or Liens that would not, individually or in the aggregate, reasonably be expected to result in a Manager Material Adverse Effect, nor
will such action result in any violation of (i) the provisions of the Organizational Documents of the Manager or (ii) except
as would not reasonably be expected to result in a Manager Material Adverse Effect, any applicable law, statute, rule, regulation, judgment,
order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Manager
or any of its assets, properties or operations.
(6) Absence
of Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree
of, any court or governmental authority or agency, domestic or foreign, is necessary or required for the authorization, execution, delivery
or performance by the Manager of this Agreement and the Management Agreement, the consummation of the transactions contemplated by this
Agreement and the Management Agreement, and in connection with the offering, issuance and sale of the Securities by the Transaction Entities,
except such as have been obtained or made and except that no representation is made as to such as may be required under state or foreign
securities laws.
(7) No
Consents Required. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, no consent,
approval, authorization, order, license, registration or qualification of or with any court or arbitrator or governmental or regulatory
authority is required for the execution, delivery and performance by the Manager of each of this Agreement or the consummation of the
transactions contemplated by this Agreement.
(8) No
Material Adverse Change in Business. Except as otherwise disclosed therein, since the respective dates as of which information
is given in the Registration Statement, the General Disclosure Package and the Prospectus (in each case exclusive of any amendments or
supplements thereto subsequent to the date of this Agreement), there has been no material adverse change or any development that could
reasonably be expected to result in a Manager Material Adverse Effect or that could prevent the Manager from carrying out its obligations
under this Agreement.
(9) Legal
Proceedings. There is no action, suit, proceeding, inquiry or investigation before or brought by any court or governmental agency
or body, domestic or foreign, now pending, or, to the knowledge of the Manager, threatened, against the Manager that might reasonably
be expected, individually or in the aggregate, to result in a Manager Material Adverse Effect, or to materially and adversely affect
the consummation of the transactions contemplated in this Agreement or the performance by the Manager of its obligations under this Agreement.
(10) Employee
Matters. The Manager has not been notified that any of the Manager’s officers, investment committee members, investment professionals
or other key persons named in the Registration Statement, the General Disclosure Package and the Prospectus plans to terminate his or
her employment or association with the Manager.
(11) Resources.
The Manager has access to personnel and other resources reasonably necessary for the performance of the duties of the Manager set forth
in the Management Agreement and as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.
(12) Possession
of Licenses and Permits. The Manager possesses such Governmental Licenses issued by the appropriate federal, state, local or foreign
regulatory agencies or bodies necessary to conduct the business now operated by it; and, except as would not, individually or in the
aggregate, reasonably be expected to have a Manager Material Adverse Effect, the Manager has not received any notice of proceedings relating
to the revocation or modification of any such Governmental Licenses.
(13) Accounting
Controls. The Manager operates under the Company’s system of internal accounting controls in order to provide reasonable assurances
that (i) transactions effectuated by it on behalf of the Company pursuant to its duties set forth in the Management Agreement are
executed in accordance with management’s general or specific authorization and (ii) access to the Company’s assets is
permitted only in accordance with management’s general or specific authorization.
(14) No
Unlawful Payments. Neither the Manager nor any of its directors or officers nor, to the knowledge of the Manager, any manager, employee
or agent of the Manager, in each case acting on behalf of the Manager, is aware of or has taken, directly or indirectly, any action that
has resulted or would result in (i) the use of any funds for any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; (ii) the making or taking of an act in furtherance of an offer, promise or authorization of any
direct or indirect unlawful payment or benefit to any foreign or domestic government or regulatory official or employee, including of
any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for
or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) a violation
by any such person of any provision of the Anti-Corruption Laws; or (iv) the making, offering, requesting or taking of, or the agreement
to take, an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence
payment, kickback or other unlawful or improper payment or benefit.
(15) Compliance
with Money Laundering Laws. The operations of the Manager are and have been conducted at all times in material compliance with applicable
Anti-Money Laundering Laws, and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority
or body or any arbitrator involving the Manager with respect to the Anti-Money Laundering Laws is pending or, to the Manager’s
knowledge, threatened.
(16) No
Conflicts with Sanction Laws. Neither the Manager nor any of its directors or officers nor, to its knowledge, any manager, agent
or employee of the Manager, in each case acting on behalf of the Manager is currently the subject of any Sanctions, nor located, organized
or resident in a Sanctioned Country; and the Manager will not directly or, indirectly cause the Transaction Entities to directly or indirectly
use any of the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
partner or other person or entity (i) for the purpose of funding or facilitating any activities of or business with any person that,
at the time of such funding or facilitation, is the subject or the target of any Sanctions, (ii) for the purpose of funding or facilitating
any activities of or any business in any Sanctioned Country or (iii) in any other manner that could result in a violation by any
person (including any person participating in the transaction, whether as an underwriter, advisor, investor or otherwise) of any Sanctions.
(17) Investment
Advisers Act. The Manager is duly registered as an investment adviser with the Commission. The Manager is not prohibited by the Investment
Advisers Act of 1940, as amended, or the rules and regulations thereunder, from performing its obligations under the Management
Agreement as described in the Registration Statement, the General Disclosure Package and the Prospectus.
(18) Free
Writing Prospectus. Without limitation to the provisions of Section 18 hereof, the Manager has not distributed and will not
distribute, directly or indirectly (other than through the Underwriters), any “written communication” (as defined Rule 405
under the 1933 Act) or other offering materials in connection with the offering or sale of the Securities, other than the Pre-Pricing
Prospectus, the Prospectus, any amendment or supplements to any of the foregoing that are filed with the Commission and any Permitted
Free Writing Prospectuses (as defined in Section 18).
(19) No
Stabilization. The Manager has not taken, directly or indirectly, any action designed to, or that could reasonably be expected
to, cause or result in any stabilization or manipulation of the price of the Securities to facilitate the sale or resale of the Securities.
(c) Certificates.
Any certificate signed by any officer of the Transaction Entities, the Manager or any of their subsidiaries (whether signed on behalf
of such officer, the Transaction Entities, the Manager or such subsidiary) and delivered to the Representatives or to counsel for the
Underwriters shall be deemed a representation and warranty by the Transaction Entities or the Manager, as applicable, to each Underwriter
as to the matters covered thereby.
SECTION 2. Sale
and Delivery to Underwriters; Closing.
(a) Securities.
On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the
Transaction Entities agree to sell to the Underwriters, severally and not jointly, the aggregate principal amount of Securities, and
each Underwriter, severally and not jointly, agrees to purchase the aggregate principal amount of Securities set forth opposite its name
in Exhibit A hereto plus any additional principal amount of Securities which such Underwriter may become obligated to purchase pursuant
to the provisions of Section 11 hereof, subject to such adjustments among the Underwriters as the Representatives in their sole
discretion shall make to ensure that the Securities are issued in minimum denominations of $25 and whole multiples of $25 in excess thereof
at a price equal to 96.850% of the principal amount thereof (the “Purchase Price”).
(b) Payment.
Payment of the purchase price for, and delivery of, the Securities shall be made at the offices of Clifford Chance US LLP, Two Manhattan
West, 375 Ninth Avenue, New York, NY 10001, or at such other place as shall be agreed upon by the Representatives and the Company, at
9:00 A.M. (New York City time) on July 25, 2024 (unless postponed in accordance with the provisions of Section 11), or
such other time not later than five business days after such date as shall be agreed upon by the Representatives and the Company (such
time and date of payment and delivery being herein called “Closing Date”).
Payment shall be made to
the Company by wire transfer of immediately available funds to a single bank account designated by the Company, in each case against
delivery to the Representatives for the respective accounts of the Underwriters of the Securities to be purchased by them. It is understood
that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the
purchase price for, the Securities which it has agreed to purchase. RBC Capital Markets, UBS Investment Bank, Wells Fargo Securities
and Piper Sandler, each individually and not as Representatives, may (but shall not be obligated to) make payment of the purchase price
for the Securities to be purchased by any Underwriter whose funds have not been received by the Closing Date, but such payment shall
not relieve such Underwriter from its obligations hereunder.
(c) Delivery
of Securities. The Company shall make one or more global certificates representing the Securities (collectively, the “Global
Securities”) available for inspection by the Representatives not later than 3:00 p.m., New York City time, on the business
day prior to the Closing Date and, on or prior to the Closing Date, the Company shall deliver the Global Securities to DTC or to the
Trustee, acting as custodian for DTC, as applicable. Delivery of the Securities to the Underwriters on the Closing Date shall be made
through the facilities of DTC unless the Representatives shall otherwise instruct.
SECTION 3. Covenants
of the Transaction Entities. Each of the Transaction Entities covenants with each Underwriter as follows:
(a) Compliance
with Securities Regulations and Commission Requests. The Company, subject to Section 3(b), will comply with the requirements
of Rule 430B and Rule 433 and will notify the Representatives immediately, and confirm the notice in writing, (i) when
the Registration Statement or any post-effective amendment to the Registration Statement shall be declared or become effective, or when
any preliminary prospectus, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement to any of the foregoing
shall have been filed or distributed, (ii) of the receipt of any comments from the Commission (and shall promptly furnish the Representatives
with a copy of any comment letters and of any written responses thereto a reasonable amount of time prior to the proposed filing thereof
with the Commission and will not file any such response to which the Representatives or counsel for the Underwriters have reasonably
objected in a timely manner), (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment
or supplement to any preliminary prospectus or the Prospectus, or any Issuer Free Writing Prospectus or for additional information, (iv) of
the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any order preventing
or suspending the use of any preliminary prospectus, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement
to any of the foregoing, or any notice from the Commission objecting to the use of the form of the Registration Statement or any post-effective
amendment thereto, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the loss
or suspension of any exemption from any such qualification, or of the initiation or threatening of any proceedings for any of such purposes,
or of any examination pursuant to Section 8(e) of the 1933 Act concerning the Registration Statement and (v) if the Company
becomes the subject of a proceeding under Section 8A of the 1933 Act in connection with the offering of the Securities. The Company
will use commercially reasonable efforts to prevent the issuance of any stop order and the suspension or loss of any qualification of
the Securities for offering or sale and any loss or suspension of any exemption from any such qualification, and if any such stop order
is issued, or any such suspension or loss occurs, to obtain the lifting thereof as soon as possible.
(b) Filing
of Amendments. The Company will give the Representatives notice of its intention to file or prepare any amendment to the Registration
Statement, any Issuer Free Writing Prospectus or any amendment, supplement or revision to any preliminary prospectus, the Prospectus
or any Issuer Free Writing Prospectus, whether pursuant to the 1933 Act or otherwise, and the Company will furnish the Representatives
with copies of any such documents within a reasonable amount of time prior to such proposed filing or use, as the case may be, and will
not file or use any such document to which the Representatives or counsel for the Underwriters have reasonably objected in a timely manner.
The Company will give the Representatives notice of its intention to make any filing pursuant to the 1934 Act or the 1934 Act Regulations
from the Applicable Time through the Closing Date (or, if later, through the end of the period during which the Prospectus is required
(or, but for the provisions of Rule 172, would be required) to be delivered by applicable law (whether to meet the requests of purchasers
pursuant to Rule 173(d) or otherwise)) and will furnish the Representatives with copies of any such documents a reasonable
amount of time prior to such proposed filing, as the case may be, and will not file or use any such document to which the Representatives
or counsel for the Underwriters have reasonably objected in a timely manner.
(c) Delivery
of Registration Statements. The Company has furnished or will deliver to the Representatives and counsel for the Underwriters, without
charge, copies of the Registration Statement and of each amendment thereto (including exhibits filed therewith) and copies of all consents
and certificates of experts.
(d) Delivery
of Prospectuses. The Company has delivered to each Underwriter, without charge, as many copies of each preliminary prospectus and
any amendments or supplements thereto as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies
for purposes permitted by the 1933 Act. The Company will furnish to each Underwriter, without charge, during the period when the Prospectus
is required (or, but for the provisions of Rule 172, would be required) to be delivered by applicable law (whether to meet the request
of purchasers pursuant to Rule 173(d) or otherwise), such number of copies of the Pre-Pricing Prospectus, the Prospectus and
any Issuer Free Writing Prospectus and any amendments or supplements to any of the foregoing as such Underwriter may reasonably request.
(e) Continued
Compliance with Securities Laws. The Company will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934 Act
Regulations so as to permit the completion of the distribution of the Securities as contemplated by this Agreement, the General Disclosure
Package and the Prospectus. If at any time when a prospectus is required (or, but for the provisions of Rule 172, would be required)
by applicable law to be delivered in connection with sales of the Securities (whether to meet the request of purchasers pursuant to Rule 173(d) or
otherwise), any event shall occur or condition shall exist as a result of which it is necessary (or if the Representatives or counsel
for the Underwriters shall notify the Company that, in their judgment, it is necessary) to amend the Registration Statement or amend
or supplement the General Disclosure Package or the Prospectus so that the Registration Statement, the General Disclosure Package or
the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made or then prevailing, not misleading
or if it is necessary (or if the Representatives or counsel for the Underwriters shall notify the Company that, in their judgment, it
is necessary) to amend the Registration Statement or amend or supplement the General Disclosure Package or the Prospectus in order to
comply with the requirements of the 1933 Act, the 1933 Act Regulations, the 1934 Act or the 1934 Act Regulations, the Company will promptly
notify the Representatives of such event or condition and of its intention to file such amendment or supplement (or, if the Representatives
or counsel for the Underwriters shall have notified the Company as aforesaid, the Company will promptly notify the Representatives of
its intention to prepare such amendment or supplement) and will promptly prepare and file with the Commission, subject to Section 3(b) hereof,
such amendment or supplement as may be necessary to correct such untrue statement or omission or to comply with such requirements, and,
in the case of an amendment or post-effective amendment to the Registration Statement, the Company will use its best efforts to have
such amendment declared or become effective as soon as practicable, and the Company will furnish to the Underwriters such number of copies
of such amendment or supplement as the Underwriters may reasonably request. If at any time an Issuer Free Writing Prospectus conflicts
with the information contained in the Registration Statement or if an event shall occur or condition shall exist as a result of which
it is necessary (or, if the Representatives or counsel for the Underwriters shall notify the Company that, in their judgment, it is necessary)
to amend or supplement such Issuer Free Writing Prospectus so that it will not include an untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made
or then prevailing, not misleading, or if it is necessary (or, if the Representatives or counsel for the Underwriters shall notify the
Company that, in their judgment, it is necessary) to amend or supplement such Issuer Free Writing Prospectus in order to comply with
the requirements of the 1933 Act or the 1933 Act Regulations, the Company will promptly notify the Representatives of such event or condition
and of its intention to file such amendment or supplement (or, if the Representatives or counsel for the Underwriters shall have notified
the Company as aforesaid, the Company will promptly notify the Representatives of its intention to prepare such amendment or supplement)
and will promptly prepare and, if required by the 1933 Act or the 1933 Act Regulations, file with the Commission, subject to Section 3(b) hereof,
such amendment or supplement as may be necessary to eliminate or correct such conflict, untrue statement or omission or to comply with
such requirements, and the Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters
may reasonably request.
(f) Blue
Sky and Other Qualifications. The Company will use its best efforts, in cooperation with the Underwriters, to qualify the Securities
for offering and sale, or to obtain an exemption for the Securities to be offered and sold, under the applicable securities laws of such
states and other jurisdictions (domestic or foreign) as the Representatives may designate and to maintain such qualifications and exemptions
in effect for so long as required for the distribution of the Securities; provided, however, that the Company shall not be obligated
to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not
otherwise so subject. In each jurisdiction in which the Securities have been so qualified or exempt, the Company will file such statements
and reports as may be required by the laws of such jurisdiction to continue such qualification or exemption, as the case may be, in effect
for so long as required for the distribution of the Securities.
(g) Rule 158.
The Company will timely file such reports pursuant to the 1934 Act as are necessary in order to make generally available to its securityholders
as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the benefits contemplated by, the
last paragraph of Section 11(a) of the 1933 Act.
(h) Use
of Proceeds. The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the
Pre-Pricing Prospectus and the Prospectus under “Use of Proceeds.”
(i) Listing.
The Company will use its best efforts to cause the Securities to be listed for trading within the time period specified in the General
Disclosure Package and to maintain such listing on the NYSE.
(j) Restriction
on Sale of Securities. Except for the Securities to be issued under this Agreement, during the Lock-Up Period, the Transaction Entities
and their subsidiaries will not, without the prior written consent of the Representatives (which consent may be withheld in the Representatives’
sole discretion), directly or indirectly:
(i) sell,
offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose
of, directly or indirectly, any debt securities issued or guaranteed by the Transaction Entities or any of their subsidiaries or any
securities convertible into or exchangeable or exercisable for debt securities issued or guaranteed by the Transaction Entities or any
of their subsidiaries; or
(ii) file,
cause the filing of or cause to be declared effective any registration statement under the 1933 Act with the Commission with respect
to any securities described in clause (i) of this section.
(k) Reporting
Requirements. The Company, during the period when the Prospectus is required (or, but for the provisions of Rule 172, would
be required) by applicable law to be delivered (whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise),
will file all documents required to be filed with the Commission pursuant to the 1934 Act and the 1934 Act Regulations within the time
periods required by the 1934 Act and the 1934 Act Regulations.
(l) Preparation
of Prospectus. Immediately following the execution of this Agreement, the Company will, subject to Section 3(b) hereof,
prepare the Prospectus, which shall contain the selling terms of the Securities, the plan of distribution thereof and such other information
as may be required by the 1933 Act or the 1933 Act Regulations or as the Representatives and the Company may deem appropriate, and, if
requested by the Representatives, will prepare an Issuer Free Writing Prospectus containing the information set forth in Exhibit F
hereto and such other information as may be required by Rule 433 or as the Representatives and the Company may deem appropriate,
and will file or transmit for filing with the Commission the Prospectus in accordance with the provisions of Rule 430B and in the
manner and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)) and any such Issuer Free
Writing Prospectus in the manner and within the time period required by Rule 433.
(m) Absence
of Manipulation. The Transaction Entities will not take, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of the price of any security
of the Company to facilitate the sale or resale of the Securities.
(n) 1940
Act. The Transaction Entities shall not invest, or otherwise use the proceeds received by the Transaction Entities from its sale
of the Securities in such a manner as would require either of the Transaction Entities to register as an investment company under the
1940 Act.
(o) Qualification
and Taxation as a REIT. The Company will use its best efforts to meet the requirements for qualification and taxation as a REIT under
the Code for its taxable year ending December 31, 2024, and the Company will use its best efforts to continue to qualify for taxation
as a REIT under the Code unless the Board determines that it is no longer in the best interest of the Company to attempt to, or continue
to, qualify as a REIT.
SECTION 4. Covenants
of the Manager. The Manager covenants with each Underwriter that it will not take, directly or indirectly, any action designed to
cause or result in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price
of any security of the Company to facilitate the sale or resale of the Securities.
SECTION 5. Payment
of Expenses.
(a) Expenses.
The Company, in order to facilitate the issuance of the Securities will pay all reasonable expenses incident to the performance of
the Transaction Entities’ obligations under this Agreement, including (i) the preparation, printing and filing of the Registration
Statement and each amendment thereto (in each case including exhibits) and any costs associated with electronic delivery of any of the
foregoing, (ii) the word processing and delivery to the Underwriters of this Agreement, the Indenture, the Securities, and such
other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Securities, (iii) the
preparation, issuance and delivery of the certificates for the Securities and the issuance and delivery of the Securities to be sold
by the Company to the Underwriters, including any issue or other transfer taxes and any stamp or other taxes or duties payable in connection
with the sale, issuance or delivery of the Securities to the Underwriters, (iv) the fees and disbursements of the counsel, accountants
and other advisors to the Company, (v) the qualification or exemption of the Securities under securities laws in accordance with
the provisions of Section 3(f) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters
in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplements thereto (provided that with
respect to fees of counsel to the Underwriters, the amount reimbursed shall in no event exceed $5,000), (vi) the preparation, printing
and delivery to the Underwriters of copies of each preliminary prospectus, any Permitted Free Writing Prospectus, and the Prospectus
and any amendments or supplements to any of the foregoing and any costs associated with electronic delivery of any of the foregoing,
(vii) the preparation, printing and delivery to the Underwriters of copies of any Blue Sky Survey and any Canadian “wrapper”
and any supplements thereto and any costs associated with electronic delivery of any of the foregoing, (viii) the fees and expenses
of the Trustee and any registrar, including the fees and disbursements of counsel for the Trustee in connection with the Indenture and
the Securities, (ix) the fees and expenses incurred in connection with the listing of the Securities on the NYSE, (x) the fees
and expenses of the Underwriters (including fees and disbursements of the counsel for the Underwriters and marketing, syndication and
travel expenses and any expenses related to an investor presentation and/or roadshow to potential investors that are incurred by the
Underwriters), provided that payment or reimbursement by the Company of such fees and expenses shall not exceed $150,000 and (xi) all
fees charged by any ratings agencies for rating the Securities and all expenses and application fees incurred in connection with the
approval of the Securities for clearance, settlement, and book entry transfer through DTC. Except as provided in this Section 5(a),
the Underwriters shall pay their own expenses, including the fees and disbursements of counsel and travel and lodging expenses.
(b) Termination
of Agreement. If this Agreement is terminated by the Representatives in accordance with the provisions of Section 6, Section 10(a)(i),
Section 10(a)(iii)(A) or Section 10(a)(v) hereof, the Company shall reimburse the Underwriters for all of their reasonable
and documented out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters.
SECTION 6. Conditions
of Underwriters’ Obligations. The obligations of the several Underwriters hereunder are subject to the accuracy of the representations
and warranties of the Transaction Entities and the Manager contained in this Agreement, or in certificates signed by any officer of the
Transaction Entities, the Manager or any of their respective subsidiaries (whether signed on behalf of such officer, the Transaction
Entities, the Manager or such subsidiary), to the performance by the Transaction Entities and the Manager of their covenants and other
obligations hereunder, and to the following further conditions:
(a) Effectiveness
of Registration Statement. The Registration Statement and any post-effective amendments thereto have been declared effective and
no stop order suspending the effectiveness of the Registration Statement shall have been issued under the 1933 Act or proceedings therefor
initiated or, to the knowledge of the Company, threatened by the Commission, and any request on the part of the Commission for additional
information shall have been complied with to the reasonable satisfaction of the Representatives and the Commission shall not have notified
the Company of any objection to the use of the form of the Registration Statement. The Prospectus shall have been filed with the Commission
in the manner and within the time period required by Rule 424(b) (without reliance upon Rule 424(b)(8)) and each Issuer
Free Writing Prospectus required to be filed with the Commission shall have been filed in the manner and within the time period required
by Rule 433.
(b) Opinion
of Counsel for Company. At the Closing Date, the Representatives shall have received the favorable opinions, dated as of the Closing
Date, of Sidley Austin LLP, counsel for the Transaction Entities and the Manager (“Company Counsel”), in form and
substance reasonably satisfactory to the Representatives, together with signed or reproduced copies of such opinion for each of the other
Underwriters, to the effect set forth in Exhibits D-1 and D-2 hereto, and the opinion, dated as of the Closing Date, of Venable LLP,
special Maryland counsel to the Company, in form and substance reasonably satisfactory to the Representatives, together with signed or
reproduced copies of such opinion for each of the other Underwriters, to the effect set forth in Exhibit E hereto.
(c) Opinion
of Counsel for Underwriters. At the Closing Date, the Representatives shall have received the favorable opinion and negative assurance
letter, dated as of Closing Date, of Clifford Chance US LLP, counsel for the Underwriters (“Underwriters’ Counsel”),
together with signed or reproduced copies of such letter for each of the other Underwriters, with respect to the Securities to be sold
by the Company pursuant to this Agreement, this Agreement, the Registration Statement, the General Disclosure Package and the Prospectus
and any amendments or supplements thereto and such other matters as the Representatives may reasonably request.
(d) Officers’
Certificate. At the Closing Date, there shall not have been, since the date hereof or since the respective dates as of which information
is given in the Registration Statement, the General Disclosure Package and the Prospectus (in each case exclusive of any amendments or
supplements thereto subsequent to the date of this Agreement), any material adverse change or any development that could reasonably be
expected to result in a material adverse change, in the condition (financial or other), results of operations, business, properties,
management or prospects of the Transaction Entities and their respective subsidiaries taken as a whole, whether or not arising in the
ordinary course of business, and, at the Closing Date, the Representatives shall have received a certificate, signed on behalf of the
Transaction Entities by the President or the Chief Executive Officer of the Company and the Chief Financial Officer or Chief Accounting
Officer of the Company (and persons having equivalent functions with respect to the Operating Partnership), dated as of the Closing Date,
to the effect that (i) there has been no such material adverse change, (ii) the representations and warranties of the Transaction
Entities in this Agreement are true and correct at and as of the Closing Date with the same force and effect as though expressly made
at and as of the Closing Date, (iii) the Transaction Entities have complied with all agreements and satisfied all conditions on
their part to be performed or satisfied at or prior to the Closing Date under or pursuant to this Agreement, and (iv) no stop order
suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or
are pending or, to the knowledge of the Transaction Entities, are contemplated by the Commission and the Commission has not notified
the Company of any objection to the use of the form of the Registration Statement.
(e) Accountant’s
Comfort Letter. At the time of the execution of this Agreement, the Representatives shall have received from KPMG LLP a letter, dated
the date of this Agreement and in form and substance reasonably satisfactory to the Representatives, together with signed or reproduced
copies of such letter for each of the other Underwriters, containing statements and information of the type ordinarily included in accountants’
“comfort letters” to underwriters with respect to the financial statements and certain financial information of the Company
contained in the Registration Statement, the General Disclosure Package, any Issuer Free Writing Prospectuses (other than any electronic
road show) and the Prospectus and any amendments or supplements to any of the foregoing.
(f) Bring-down
Comfort Letter. At the Closing Date, the Representatives shall have received from KPMG LLP a letter, dated as of Closing Date and
in form and substance reasonably satisfactory to the Representatives, to the effect that they reaffirm the statements made in the letter
furnished pursuant to subsection (e) of this Section, except that the specified date referred to shall be a date not more than three
business days prior to Closing Date.
(g) Exchange
Listing and DTC. An application for the listing of the Securities shall have been submitted to the NYSE. At the Closing Date, the
Securities shall be eligible for clearance and settlement through DTC.
(h) Chief
Financial Officer’s Certificate. At the time of the execution of this Agreement and at the Closing Date, the Representatives
shall have received a certificate, signed on behalf of the Company by the Chief Financial Officer of the Company, dated as of the Closing
Date, in form and substance reasonably satisfactory to the Representatives, certifying certain financial information contained in the
Registration Statement, the General Disclosure Package and the Prospectus.
(i) Manager
Officers’ Certificate. At the Closing Date, there shall not have been, since the date hereof or since the respective dates
as of which information is given in the Registration Statement, the General Disclosure Package and the Prospectus (in each case exclusive
of any amendments or supplements thereto subsequent to the date of this Agreement), any material adverse change or any development that
could reasonably be expected to result in a material adverse change in the condition (financial or other), results of operations, business,
properties, management or prospects of the Manager, and, at the Closing Date, the Representatives shall have received a certificate,
signed on behalf of the Manager by the President and Treasurer of the Manager (or persons having equivalent functions), dated as of the
Closing Date, to the effect that (i) there has been no such material adverse change, (ii) the representations and warranties
of the Manager in this Agreement are true and correct at and as of the Closing Date with the same force and effect as though expressly
made at and as of the Closing Date and (iii) the Manager has complied with all agreements and satisfied all conditions on its part
to be performed or satisfied at or prior to the Closing Date under or pursuant to this Agreement.
(j) Additional
Documents. At the Closing Date, counsel for the Underwriters shall have been furnished with such documents and opinions as they may
reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in
order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, contained in
this Agreement, or as the Representatives or counsel for the Underwriters may otherwise reasonably request.
(k) Termination
of Agreement. If any condition specified in this Section 6 shall not have been fulfilled when and as required to be fulfilled,
this Agreement may be terminated by the Representatives by notice to the Company at any time on or prior to Closing Date and such termination
shall be without liability of any party to any other party except as provided in Section 5 hereof and except that, in the case of
any such termination of this Agreement, Sections 7, 8, 9, 15, 17, 19 and 21 hereof shall survive such termination of this Agreement and
remain in full force and effect.
(l) No
Rating Event. Between the date of this Agreement and the Closing Date, there shall not have occurred any downgrading in the rating
of debt securities, if any, of the Transaction Entities by any “nationally recognized statistical rating organization” (as
defined in Section 3(a)(62) of the 1934 Act), or any public announcement that any such organization has under surveillance or review
its rating of any debt securities of the Transaction Entities (other than an announcement with positive implications of a possible upgrading,
and no implication of a possible downgrading, of such rating).
SECTION 7. Indemnification.
(a) Indemnification
by the Transaction Entities. Each of the Transaction Entities, jointly and severally, agrees to indemnify and hold harmless each
Underwriter, its affiliates, and its officers, directors, employees, partners and members and each person, if any, who controls any Underwriter
within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows:
(i) against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission
therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out
of any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, any Issuer Free Writing
Prospectus, the General Disclosure Package or the Prospectus (or any amendment or supplement to any of the foregoing), or in any “road
show” (as defined in Rule 433) that does not constitute an Issuer Free Writing Prospectus, or the omission or alleged omission
therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading;
(ii)
against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding
by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission,
or any such alleged untrue statement or omission; provided that (subject to Section 7(d) below) any such settlement is effected
with the written consent of the Transaction Entities; and
(iii) against
any and all expense whatsoever, as incurred (including the fees and disbursements of counsel), reasonably incurred in investigating,
preparing for or defending against any such loss, liability, claim, damage or litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged
untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above, provided,
however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of
any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives expressly for use in the Registration Statement (or any amendment
thereto), or in any preliminary prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package or the Prospectus (or
in any amendment or supplement to any of the foregoing), it being understood and agreed that the only such information furnished by the
Underwriters as aforesaid consists of the information described as such in Section 7(b) hereof.
(b) Indemnification
by the Underwriters. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Transaction Entities,
their respective directors, each of the Company’s officers who signed the Registration Statement and each person, if any, who controls
either of the Transaction Entities within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act against any
and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section 7,
as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration
Statement (or any amendment thereto), or in any preliminary prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package
or the Prospectus (or any amendment or supplement to any of the foregoing), in reliance upon and in conformity with written information
furnished to the Company by such Underwriter through the Representatives expressly for use therein. The Company hereby acknowledges and
agrees that the information furnished to the Company by the Underwriters through the Representatives expressly for use in the Registration
Statement (or any amendment thereto), or in any preliminary prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package
or the Prospectus (or any amendment or supplement to any of the foregoing), consists exclusively of the following information appearing
under the caption “Underwriting” in the Pre-Pricing Prospectus and the Prospectus: (i) the names of the Underwriters
and their respective participation in the sale of the Securities; and (ii) the information regarding concession and reallowance
in the third paragraph under such caption and the information regarding stabilization, syndicate covering transactions and penalty bids
appearing in the tenth paragraph (and all sub-bullets) under such caption.
(c) Actions
Against Parties; Notification. Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying
party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying
party shall not relieve such indemnifying party from any liability hereunder. Counsel to the indemnified parties shall be selected as
follows: counsel to the Underwriters and the other indemnified parties referred to in Section 7(a) above shall be selected
by the Representatives, and counsel to the Transaction Entities and the other indemnified parties referred to in Section 7(b) above
shall be selected by the Transaction Entities. An indemnifying party may participate at its own expense in the defense of any such action;
provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel
to the indemnified party. In no event shall the indemnifying party be liable for the fees and expenses of more than one counsel (in addition
to any local counsel) separate from their own counsel for the Underwriters and the other indemnified parties referred to in Section 7(a) above,
and the fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for the Transaction
Entities and the other indemnified parties referred to in Section 7(b) above, in each case in connection with any one action
or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No
indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry
of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened,
or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 7 or Section 8
hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent
(i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation,
proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or
on behalf of any indemnified party.
(d) Settlement
Without Consent if Failure to Reimburse. If at any time an indemnified party shall have requested an indemnifying party to reimburse
the indemnified party for fees and expenses of counsel as contemplated by this Section 7, such indemnifying party agrees that it
shall be liable for any settlement of the nature contemplated by Section 7(a)(ii) effected without its written consent if (i) such
settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying
party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such
indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.
SECTION 8. Contribution.
If the indemnification provided for in Section 7 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified
party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute
to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i) in
such proportion as is appropriate to reflect the relative benefits received by the Transaction Entities on the one hand and the Underwriters
on the other hand from the offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) above but also the relative fault of the Transaction Entities on the one hand and of the Underwriters on the other hand in connection
with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant
equitable considerations.
The relative benefits received
by the Transaction Entities on the one hand and the Underwriters on the other hand in connection with the offering of the Securities
pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the
Securities pursuant to this Agreement (before deducting expenses) received by the Company and the total underwriting discounts and commissions
received by the Underwriters, in each case as set forth on the cover of the Prospectus, bear to the aggregate initial public offering
price of the Securities as set forth on such cover.
The relative fault of the
Transaction Entities on the one hand and the Underwriters on the other hand shall be determined by reference to, among other things,
whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates
to information supplied by the Company on the one hand or by the Underwriters on the other hand and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Transaction Entities
and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which
does not take account of the equitable considerations referred to above in this Section 8. The aggregate amount of losses, liabilities,
claims, damages and expenses incurred by an indemnified party and referred to above in this Section 8 shall be deemed to include
any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing for or defending against any litigation,
or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any
such untrue or alleged untrue statement or omission or alleged omission.
Notwithstanding the provisions
of this Section 8, no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at
which the Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which
such Underwriter has otherwise been required to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission.
No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who
was not guilty of such fraudulent misrepresentation.
For purposes of this Section 8,
each affiliate of any Underwriter, each officer, director, employee, partner and member of any Underwriter, and each person, if any,
who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the
same rights to contribution as such Underwriter, and each director of the Transaction Entities, each officer of the Company who signed
the Registration Statement, and each person, if any, who controls either of the Transaction Entities within the meaning of Section 15
of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Transaction Entities. The Underwriters’
respective obligations to contribute pursuant to this Section 8 are several in proportion to the aggregate principal amount set
forth opposite their respective names in Exhibit A hereto and not joint.
SECTION 9. Representations,
Warranties and Agreements to Survive Delivery. All representations, warranties and agreements contained in this Agreement or in certificates
signed by any officer of the Manager, the Transaction Entities or any of their respective subsidiaries (whether signed on behalf of such
officer, the Manager, the Transaction Entities or such subsidiary) and delivered to the Representatives or counsel to the Underwriters,
shall remain operative and in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, any officer,
director, employee, partner, member or agent of any Underwriter or any person controlling any Underwriter, or by or on behalf of the
Manager, the Transaction Entities, any officer, director or employee of the Manager, the Transaction Entities or any person controlling
the Manager or the Transaction Entities, and shall survive delivery of and payment for the Securities.
SECTION 10. Termination
of Agreement.
(a) Termination;
General. The Representatives may terminate this Agreement, by notice to the Company, at any time on or prior to Closing Date (i) if
there has been, at any time on or after the date of this Agreement or since the respective dates as of which information is given in
the General Disclosure Package or the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the date
of this Agreement), any material adverse change or any development that could reasonably be expected to result in a material adverse
change in the condition (financial or other), results of operations, business, properties, management or prospects of the Transaction
Entities and their respective subsidiaries taken as a whole, whether or not arising in the ordinary course of business, or (ii) if
there has occurred any material adverse change in the financial markets in the United States or the international financial markets,
any declaration of a national emergency or war by the United States, any outbreak of hostilities or escalation thereof or other calamity
or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions
(including, without limitation, as a result of terrorist activities), in each case the effect of which is such as to make it, in the
judgment of the Representatives, impracticable or inadvisable to market the Securities or to enforce contracts for the sale of the Securities,
or (iii) if (A) trading in any securities of the Company has been suspended or materially limited by the Commission or the
NYSE, or (B) trading generally on the NYSE, the Nasdaq Global Select Market, the Nasdaq Global Market or the NYSE Amex has been
suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required,
by any of such exchanges or by order of the Commission, FINRA or any other governmental authority, or (C) a material disruption
has occurred in commercial banking or securities settlement or clearance services in the United States or in Europe, or (iv) if
a banking moratorium has been declared by either Federal or New York authorities or (v) if there shall have occurred, at any time
on or after the date of this Agreement, any downgrading in the rating of any debt securities of or guaranteed by the Company, any preferred
stock of the Company or any debt securities, preferred stock or trust preferred securities of any subsidiary or subsidiary trust of the
Company by any “nationally recognized statistical rating organization” (as defined in Section 3(a)(62) of the 1934 Act)
or any public announcement that any such organization has placed its rating on the Company or any such debt securities, preferred stock
or other securities under surveillance or review or on a so-called “watch list” (other than an announcement with positive
implications of a possible upgrading, and no implication of a possible downgrading, of such rating) or any announcement by any such organization
that the Company or any such debt securities, preferred stock or other securities has been placed on negative outlook.
(b) Liabilities.
If this Agreement is terminated pursuant to this Section 10, such termination shall be without liability of any party to any
other party except as provided in Section 5 hereof and except that Sections 7, 8, 9, 15, 17, 19 and 21 hereof shall survive such
termination and remain in full force and effect.
SECTION 11. Default
by One or More of the Underwriters.
(a) If
one or more of the Underwriters shall fail at the Closing Date to purchase the Securities which it or they are obligated to purchase
under this Agreement (the “Defaulted Securities”), the Representatives shall have the right, within 24 hours thereafter,
to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters, to purchase all, but not less than
all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives
shall not have completed such arrangements within such 24-hour period, then:
(1) if
the aggregate principal amount of Defaulted Securities does not exceed 10% of the aggregate principal amount of Securities to be purchased
on such date, each of the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount of such
Defaulted Securities in the proportions that their respective underwriting obligations hereunder bear to the underwriting obligations
of all non-defaulting Underwriters; or
(2) if
the aggregate principal amount of Defaulted Securities exceeds 10% of the aggregate principal amount of Securities to be purchased on
such date, this Agreement shall terminate without liability on the part of any non-defaulting Underwriter.
No action taken pursuant
to this Section 11(a) shall relieve any defaulting Underwriter from liability in respect of its default.
In the event of any such
default which does not result in a termination of this Agreement the Representatives shall have the right to postpone the Closing Date
for a period not exceeding seven days in order to effect any required changes in the Registration Statement, the General Disclosure Package
or Prospectus or in any other documents or arrangements. As used herein, the term “Underwriter” includes any person substituted
for an Underwriter under this Section 11.
SECTION 12. Notices.
All notices and other communications hereunder shall be in writing, shall be effective only upon receipt and shall be mailed, delivered
by hand or overnight courier, or transmitted by fax (with the receipt of such fax to be confirmed by telephone). Notices to the Underwriters
shall be directed to the Representatives at RBC Capital Markets, LLC, Brookfield Place, 200 Vesey Street, 8th Floor, New York,
New York, 10281, Attention: DCM Transaction Management/Scott Primrose, telephone: 212-618-7706, email: TMGUS@rbccm.com; UBS Securities
LLC, 1285 Avenue of the Americas, New York, New York 10019, Attention of Fixed Income Syndicate, telephone; 203-719-1088; Wells Fargo
Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, North Carolina 28202, Attention: Transaction Management, Email:
tmgcapitalmarkets@wellsfargo.com; and Piper Sandler & Co., 1251 Avenue of the Americas, 6th Floor, New York, New
York 10020, Attn: Debt Capital Markets, with a copy to Piper Sandler General Counsel: 1251 Avenue of the Americas, 6th Floor,
New York, New York 10020 (email: LegalCapMarkets@psc.com); notices to the Transaction Entities and the Manager shall be directed to Angel
Oak Mortgage REIT, Inc., 3344 Peachtree Road NE, Suite 1725, Atlanta, Georgia 30326, Attention of Brandon Filson.
SECTION 13. Recognition
of the U.S. Special Resolution Regimes.
(a) In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
were governed by the laws of the United States or a state of the United States.
(b) In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.
SECTION 14. Parties.
This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Transaction Entities and the Manager and their
respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or
corporation, other than the Underwriters, the Transaction Entities and the Manager and their respective successors and the controlling
persons and other indemnified parties referred to in Sections 7 and 8 and their successors, heirs and legal representatives, any legal
or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions
and provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters, the Transaction Entities and the Manager
and their respective successors, and said controlling persons and other indemnified parties and their successors, heirs and legal representatives,
and for the benefit of no other person or entity. No purchaser of Securities from any Underwriter shall be deemed to be a successor by
reason merely of such purchase.
SECTION 15. GOVERNING
LAW AND TIME. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EXCEPT AS OTHERWISE
EXPRESSLY SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.
SECTION 16. Effect
of Headings; Counterparts. The Section and Exhibit headings herein are for convenience only and shall not affect the construction
hereof. This Agreement shall be valid, binding, and enforceable against a party only when executed by an authorized individual on behalf
of the party by means of (i) an electronic signature that complies with the New York Electronic Signatures and Records Act (N.Y.
State Tech. §§ 301-309), as amended from time to time, the federal Electronic Signatures in Global and National Commerce Act,
state enactments of the Uniform Electronic Transactions Act, or any other relevant and applicable electronic signatures law; (ii) an
original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or faxed, scanned,
or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original
manual signature. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but
such counterparts shall, together, constitute only one instrument.
SECTION 17. Definitions.
As used in this Agreement, the following terms have the respective meanings set forth below:
“Applicable Time”
means 3:42 p.m. (New York City time) on July 18, 2024 or such other time as agreed by the Company and the Representatives.
“Base
Prospectus” means the base prospectus included in the Registration Statement
“BHC Act Affiliate”
has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
“Commission”
means the Securities and Exchange Commission.
“Company Documents”
means (i) all Subject Instruments and (ii) all other contracts, indentures, mortgages, deeds of trust, loan or credit agreements,
bonds, notes, debentures, evidences of indebtedness, swap agreements, hedging agreements, leases or other instruments or agreements to
which the Company or any of its subsidiaries is a party or by which the Company, the Operating Partnership or any of their respective
subsidiaries is bound or to which any of the property or assets of the Company, the Operating Partnership or any of their respective
subsidiaries is subject.
“Covered Entity”
means any of the following:
(i) a
“covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii) a
“covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(iii) a
“covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Default Right”
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1,
as applicable.
“DTC”
means The Depository Trust Company.
“EDGAR”
means the Commission’s Electronic Data Gathering, Analysis and Retrieval System.
“ERISA”
means the U.S. Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder.
“FINRA”
means the Financial Industry Regulatory Authority, Inc. or the National Association of Securities Dealers, Inc., or both, as
the context shall require.
“GAAP”
means U.S. generally accepted accounting principles.
“IRS”
means the U.S. Internal Revenue Service.
“Issuer Free Writing
Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433, relating to the offering of
the Securities that (i) is required to be filed with the Commission by the Company, (ii) is a “road show” that
is a “written communication” within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission,
or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Securities or of
the offering that does not reflect the final terms, and all free writing prospectuses that are listed in Exhibit F hereto, in each
case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company’s
records pursuant to Rule 433(g).
“Issuer General
Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
investors, as evidenced by its being specified in Exhibit F hereto.
“Issuer Limited
Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.
“Lien”
means any security interest, mortgage, pledge, lien, encumbrance, claim or equity.
“Lock-Up Period”
means the period beginning on and including the date of this Agreement through and including the date that is the 30th day
after the date of this Agreement.
“Management Agreement”
means the amended and restated management agreement among the Company, the Operating Partnership and the Manager, dated as of May 1,
2024.
“NYSE”
means the New York Stock Exchange.
“OFAC”
means the Office of Foreign Assets Control of the U.S. Treasury Department.
“Operating Partnership
Agreement” means the Amended and Restated Limited Partnership Agreement of the Operating Partnership, dated June 21, 2021.
“OP Units”
means units of limited partner interest in the Operating Partnership.
“Organizational
Documents” means (a) in the case of a corporation, its charter and by-laws; (b) in the case of a limited or general
partnership, its partnership certificate, certificate of formation or similar organizational document and its partnership agreement;
(c) in the case of a limited liability company, its articles of organization, certificate of formation or similar organizational
documents and its operating agreement, limited liability company agreement, membership agreement or other similar agreement; (d) in
the case of a trust, its certificate of trust, certificate of formation or similar organizational document and its trust agreement or
other similar agreement; and (e) in the case of any other entity, the organizational and governing documents of such entity.
“PCAOB”
means the Public Company Accounting Oversight Board (United States).
“Pre-Pricing Prospectus”
means the preliminary prospectus dated July 18, 2024 relating to the Securities, together with the Base Prospectus, in the form
first furnished to the Underwriters for use in connection with the offering of the Securities.
“preliminary prospectus”
means each preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus as so supplemented) that describes
the Securities and the offering thereof, that omitted the Rule 430B Information and that was used prior to the filing of the Prospectus
Supplement. The term “preliminary prospectus” includes, without limitation, the Pre-Pricing Prospectus.
“Prospectus”
means the Prospectus Supplement and the Base Prospectus, in the form first filed pursuant to Rule 424(b) after the Applicable
Time, including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under
the 1933 Act.
“Prospectus Supplement”
means the prospectus supplement relating to the Securities dated July 18, 2024, together with the Base Prospectus.
“Registration Rights
Agreement” means the registration rights agreements among (i) the Company, the Manager and NHTV Atlanta Holdings LP, Xylem
Finance LLC and VPIP AO MF LLC and the other parties thereto, (ii) the Company and CPPIB and (iii) the Company and the Manager.
“Registration
Statement” means the Company’s and the Operating Partnership’s registration statement on Form S-3 (Registration
Nos. 333-280531 and 333-280531-01), as amended (if applicable), including the documents incorporated or deemed to be incorporated by
reference therein pursuant to Item 12 of Form S-3 under the 1933 Act and the Rule 430B Information; provided that any Rule 430B
Information shall be deemed to be part of the Registration Statement only from and after the time specified pursuant to Rule 430B.
“Regulation S-T”
means Regulation S-T of the Commission.
“Repayment Event”
means any event or condition which, either immediately or with notice or passage of time or both, (i) gives the holder of any bond,
note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company or any subsidiary of the Company, or (ii) gives
any counterparty (or any person acting on such counterparty’s behalf) under any swap agreement, hedging agreement or similar agreement
or instrument to which the Company or any subsidiary of the Company is a party the right to liquidate or accelerate the payment obligations
or designate an early termination date under such agreement or instrument, as the case may be.
“Rule 164,”
“Rule 172,” “Rule 173,” “Rule 405,” “Rule 424(b),”
“Rule 430B,” and “Rule 433” refer to such rules under the 1933 Act.
“Rule 430B
Information” means the information included in any preliminary prospectus or the Prospectus or any amendment or supplement
to any of the foregoing that was omitted from the Registration Statement at the time it first became effective but that is deemed to
be a part of and included in the Registration Statement pursuant to Rule 430B.
“Sarbanes-Oxley
Act” means the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder or implementing the provisions
thereof.
“Shareholder Rights
Agreement” means the shareholder rights agreements entered into by the Company and the Manager with each of NHTV Atlanta Holdings
LP and Xylem Finance LLC.
“Stockholder Documents”
means, together, the Shareholder Rights Agreement and the Registration Rights Agreement.
“Subject Instruments”
means the Stockholder Documents and all other instruments, agreements and documents incorporated by reference into the Registration Statement
or filed as exhibits to the Registration Statement pursuant to Rule 601(b)(10) of Regulation S-K of the Commission; provided
that if any instrument, agreement or other document incorporated by reference into or filed as an exhibit to the Registration Statement
as aforesaid has been redacted or if any portion thereof has been deleted or is otherwise not incorporated by reference into or included
as part of such exhibit (whether pursuant to a request for confidential treatment or otherwise), the term “Subject Instruments”
shall nonetheless mean such instrument, agreement or other document, as the case may be, in its entirety, including any portions thereof
which shall have been so redacted, deleted or otherwise not filed.
“Termination Event”
means any event or condition which gives any person the right, either immediately or with notice or passage of time or both, to terminate
or limit (in whole or in part) any Company Documents or any rights of the Company or any of its subsidiaries thereunder, including, without
limitation, upon the occurrence of a change of control of the Company or other similar events.
“U.S. Special Resolution
Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title
II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
“1933 Act”
means the Securities Act of 1933, as amended.
“1933 Act Regulations”
means the rules and regulations of the Commission under the 1933 Act.
“1934 Act”
means the Securities Exchange Act of 1934, as amended.
“1934 Act Regulations”
means the rules and regulations of the Commission under the 1934 Act.
“1939
Act” means the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder.
“1940 Act”
means the Investment Company Act of 1940, as amended.
All references in this Agreement
to the Registration Statement, , any preliminary prospectus, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement
to any of the foregoing shall be deemed to include the version thereof filed with the Commission pursuant to EDGAR and all versions thereof
delivered (physically or electronically) to the Representatives or the Underwriters.
SECTION 18. Permitted
Free Writing Prospectuses. The Company represents, warrants and agrees that it has not made and, unless it obtains the prior written
consent of the Representatives, it will not make, any offer relating to the Securities that constitutes or would constitute an “issuer
free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing
prospectus” (as defined in Rule 405) or portion thereof required to be filed with the Commission or required to be retained
by the Company pursuant to Rule 433; provided that the prior written consent of the Representatives shall be deemed to have been
given in respect of the Issuer General Use Free Writing Prospectuses, if any, listed on Exhibit F hereto, and to any electronic
road show in the form previously provided by the Company to and approved by the Representatives. Any such free writing prospectus consented
to or deemed to have been consented to as aforesaid is hereinafter referred to as a “Permitted Free Writing Prospectus.”
The Company represents, warrants and agrees that it has treated and will treat each Permitted Free Writing Prospectus as an “issuer
free writing prospectus,” as defined in Rule 433, has complied and will comply with the requirements of Rule 433 applicable
to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For
the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit F hereto are Permitted
Free Writing Prospectuses.
SECTION 19. Absence
of Fiduciary Relationship. Each of the Transaction Entities and the Manager acknowledges and agrees that:
(a) each
of the Underwriters is acting solely as an underwriter in connection with the sale of the Securities and no fiduciary, advisory or agency
relationship between the Transaction Entities and the Manager, on the one hand, and any of the Underwriters, on the other hand, has been
created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not any of the Underwriters
has advised or is advising the Transaction Entities and the Manager on other matters and no Underwriter has any obligation to the Transaction
Entities or the Manager with respect to the offering of the Securities except the obligations expressly set forth in this Agreement;
(b) the
public offering price of the Securities and the price to be paid by the Underwriters for the Securities set forth in this Agreement were
established by the Company following discussions and arms-length negotiations with the Representatives, and does not constitute a recommendation,
investment advice, or solicitation of any action by the Underwriters;
(c) it
is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated
by this Agreement;
(d) it
is aware that the Underwriters and their respective affiliates are engaged in a broad range of transactions which may involve interests
that differ from those of the Transaction Entities and the Manager and that none of the Underwriters has any obligation to disclose such
interests and transactions to the Transaction Entities and the Manager by virtue of any fiduciary, advisory or agency relationship or
otherwise;
(e) it
waives, to the fullest extent permitted by law, any claims it may have against any of the Underwriters for breach of fiduciary duty or
alleged breach of fiduciary duty relating to the transactions contemplated by this Agreement and agrees that none of the Underwriters
shall have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim
or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Transaction Entities and the Manager or any
stockholders, employees or creditors of the Transaction Entities or the Manager;
(f) the
information and transactions contemplated in this Agreement do not constitute an offer or a solicitation of an offer to transact in any
securities or other financial instrument with any natural person; and
(g) none
of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment
advice or solicitation of any action by the Underwriters with respect to any entity or natural person.
SECTION 20. Research
Analyst Independence. The Transaction Entities and the Manager acknowledge that the Underwriters’ respective research analysts
and research departments are required to be independent from their respective investment banking divisions and are subject to certain
regulations and internal policies, and that such Underwriters’ respective research analysts and research departments may hold views
and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that
differ from the views of their respective investment banking divisions. The Transaction Entities and the Manager hereby waive and release,
to the fullest extent permitted by applicable law, any claims that the Transaction Entities and the Manager may have against the Underwriters
with respect to any conflict of interest that may arise from the fact that the views expressed by their respective research analysts
and research departments may be different from or inconsistent with the views or advice communicated to the Transaction Entities and
the Manager by such Underwriters’ respective investment banking divisions. The Transaction Entities and the Manager acknowledge
that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws,
may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities
of the Company and other entities that may be the subject of the transactions contemplated by this Agreement.
SECTION 21. TRIAL
BY JURY. EACH OF THE TRANSACTION ENTITIES AND THE MANAGER AND EACH OF THE UNDERWRITERS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY.
[Signature Page Follows]
If the foregoing is in accordance
with your understanding of our agreement, please sign and return to the Transaction Entities and the Manager a counterpart hereof, whereupon
this instrument, along with all counterparts, will become a binding agreement among the Underwriters, the Transaction Entities and the
Manager in accordance with its terms.
| Very truly yours, |
| |
| ANGEL OAK MORTGAGE REIT, INC. |
| |
| By: |
/s/ Brandon Filson |
| |
Name: Brandon Filson |
| |
Title: Chief Financial Officer and Treasurer |
| |
| ANGEL OAK MORTGAGE
OPERATING PARTNERSHIP, LP |
| |
| By: |
Angel Oak Mortgage OP GP, LLC, its general partner |
| |
| By: |
Angel Oak Mortgage REIT, Inc., its sole member |
| |
| By: |
/s/ Brandon Filson |
| |
Name: Brandon Filson |
| |
Title: Chief Financial Officer and Treasurer |
| |
| FALCONS I, LLC |
| |
| By: |
/s/ Brandon Filson |
| |
Name: Brandon Filson |
| |
Title: Treasurer |
[Signature Page to Underwriting
Agreement]
CONFIRMED AND ACCEPTED, as of the date first above written: | |
RBC CAPITAL MARKETS, LLC | |
By: |
RBC CAPITAL MARKETS, LLC | |
| |
By: |
/s/ Saurabh Monga | |
|
Authorized Signatory | |
| |
UBS SECURITIES LLC | |
By: |
UBS SECURITIES LLC | |
| |
By: |
/s/ Jay Anderson | |
|
Jay Anderson | |
| |
By: |
/s/ Aaron Dupere | |
|
Aaron Dupere | |
| |
WELLS FARGO SECURITIES, LLC | |
By: |
WELLS FARGO SECURITIES, LLC | |
| |
By: |
/s/ Carolyn Hurley | |
|
Authorized Signatory | |
| |
PIPER SANDLER & CO. | |
By: |
PIPER SANDLER & CO. | |
| |
By: |
/s/ Thomas Howland | |
|
Authorized Signatory | |
For themselves and as Representatives of the
Underwriters named in Exhibit A hereto.
[Signature Page to Underwriting
Agreement]
EXHIBIT A
Name of Underwriter | |
Aggregate Principal Amount of Securities to be Purchased | |
RBC Capital Markets, LLC | |
$ | 10,250,000 | |
UBS Securities LLC | |
$ | 10,250,000 | |
Wells Fargo Securities, LLC | |
$ | 10,250,000 | |
Piper Sandler & Co. | |
$ | 9,250,000 | |
B. Riley Securities, Inc. | |
$ | 5,000,000 | |
Janney Montgomery Scott LLC | |
$ | 5,000,000 | |
Total | |
$ | 50,000,000 | |
EXHIBIT B
SUBSIDIARIES OF THE COMPANY
Name | |
| Jurisdiction of Organization | | |
Type of Entity | |
Names of General Partners/Managing Members |
Angel Oak Mortgage Operating Partnership, LP | |
| Delaware | | |
Limited Partnership | |
Angel Oak Mortgage OP GP, LLC |
Angel Oak Mortgage OP GP, LLC | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage, REIT Inc. |
Angel Oak Mortgage REIT TRS, LLC | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage Operating Partnership, LP |
AOMI SPV LLC | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage REIT TRS, LLC |
Angel Oak Mortgage Fund TRS | |
| Delaware | | |
Statutory Trust | |
Not applicable |
AOMR TRS SPE, LLC | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage REIT TRS, LLC |
AOMR-REO, LLC | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage REIT TRS, LLC |
Spruce Mortgage Trust | |
| Delaware | | |
Statutory Trust | |
Not applicable |
AOMT II, LLC* | |
| Delaware | | |
Limited Liability Company | |
Angel Oak Mortgage Operating Partnership, LP |
*AOMT II, LLC is the depositor with respect to six securitization
trusts that are not listed in this Exhibit B.
EXHIBIT C
PRICING TERM SHEET
Filed Pursuant to Rule 433 of the Securities
Act of 1933
Issuer Free Writing Prospectus dated July 18,
2024
Relating to Preliminary Prospectus Supplement
dated July 18, 2024
and Prospectus dated July 9, 2024
Registration Nos. 333-280531 and 333-280531-01
Pricing Terms
Angel Oak Mortgage REIT, Inc.
$50,000,000
9.500% Senior Notes due 2029
Pricing Term Sheet
July 18, 2024
The following sets forth the final terms of
the 9.500% Senior Notes due 2029 (the “Notes”) and should only be read together with the preliminary prospectus supplement,
dated July 18, 2024, together with the accompanying prospectus, dated July 9, 2024, relating to these securities (together,
the “Preliminary Prospectus”) and supersedes the information in the Preliminary Prospectus to the extent inconsistent with
the information in the Preliminary Prospectus. In all other respects, this pricing term sheet is qualified in its entirety by reference
to the Preliminary Prospectus. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary
Prospectus. All references to dollar amounts are references to U.S. dollars.
Issuer: |
Angel
Oak Mortgage REIT, Inc., a Maryland corporation (the “Company”) |
|
|
|
|
Guarantee: |
The
Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Angel Oak Mortgage Operating Partnership, LP, a
Delaware limited partnership (the “Guarantor”). |
|
|
|
|
Title
of the Securities: |
9.500%
Senior Notes due 2029 (the “Notes”) |
|
|
|
|
Type
of Offering: |
SEC
Registered |
|
|
|
|
Aggregate
Principal Amount Being Offered: |
$50,000,000 |
|
|
|
|
Over-Allotment
Option: |
The
underwriters for this offering do not have an over-allotment option to purchase additional Notes. |
|
|
|
|
Type
of Note: |
Fixed
rate note |
|
|
|
|
Stated
Maturity Date: |
July 30,
2029 |
|
|
|
|
Interest
Rate: |
9.500% |
|
|
|
|
Trade
Date: |
July 18,
2024 |
|
|
|
|
Settlement
Date: |
July 25,
2024 (T+5)** |
|
|
|
|
Interest
Payment Dates: |
Each
January 30, April 30, July 30 and October 30, commencing on October 30, 2024. If an interest payment date
falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will
accrue as a result of such delayed payment. |
|
|
|
|
Interest
Periods: |
The
initial interest period will be the period from and including July 25, 2024, to, but excluding, the initial interest payment
date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the
next interest payment date or the stated maturity date, as the case may be. |
|
|
|
|
Day
Count Basis: |
360-day
year of twelve 30-day months |
|
|
|
|
Issue
Price: |
$25.00 |
|
|
|
|
Price
to Issuer: |
$24.2125 |
|
|
|
|
Net
Proceeds to the Issuer, after the Underwriting Discount, before Expenses: |
$48,425,000
total |
|
|
|
|
Use
of Proceeds: |
The
Company intends to use the majority of the net proceeds from the offering for general corporate purposes, which may include the acquisition
of non-qualified residential mortgage loans and other target assets primarily sourced from Angel Oak Mortgage Lending (as defined
in the Preliminary Prospectus) or other target assets through the secondary market in a manner consistent with the Company’s
strategy and investment guidelines. Additionally, the Company intends to use the net proceeds from this offering to repurchase approximately
$20.0 million of shares of its common stock, par value $0.01 per share, owned by Xylem Finance LLC (“Xylem”), an affiliate
of Davidson Kempner Capital Management LP, pursuant to the Company’s stock repurchase agreement with Xylem. |
|
|
|
|
Denominations: |
$25.00
and integral multiples of $25.00 in excess thereof. |
|
|
|
|
Optional
Redemption: |
The Notes may be redeemed in whole or in
part at any time or from time to time at the Company’s option on or after July 30, 2026, upon not less than 30 days’
nor more than 60 days’ notice to holders prior to the redemption date, at a redemption price equal to 100% of the outstanding
principal amount of the Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.
|
|
Change
of Control Offer to Repurchase: |
Upon
a Change of Control Repurchase Event (as defined in the Preliminary Prospectus), the Company
will be required to make an offer to repurchase all outstanding Notes at a price in cash equal to 101% of the principal amount of
the Notes, plus accrued and unpaid interest to, but excluding, the repurchase date. |
|
|
|
|
CUSIP
/ ISIN: |
CUSIP:
03464Y 207 |
|
|
ISIN:
US03464Y2072 |
|
|
|
|
Expected
Rating:* |
[*] |
|
|
|
|
Listing: |
The
Company intends to apply to list the Notes on the New York Stock Exchange under the trading symbol “AOMN” and expects
trading of the Notes to commence within 30 days after the original issue date |
|
|
|
|
Joint
Book-Running Managers: |
RBC
Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC and Piper Sandler &
Co. |
|
Co-Managers: |
B. Riley Securities, Inc. and Janney Montgomery Scott LLC |
|
|
|
|
Trustee: |
U.S.
Bank Trust Company, National Association |
|
|
* Note: A securities rating is not a recommendation
to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
** Under Rule 15c6-1 of the Securities Exchange
Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade
expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to their delivery will be required, by virtue of
the fact that the Notes will initially settle T+5, to specify an alternative settlement arrangement at the time of any such trade to
prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to their date of delivery should consult their
own advisors.
This communication is intended for the sole
use of the person to whom it is provided by the issuer.
The Company and the Guarantor have filed a registration
statement (including a base prospectus dated July 9, 2024) and a preliminary prospectus supplement dated July 18, 2024 with
the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you
should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information
about the issuer and this offering.
You may get these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Company, the Guarantor, any underwriter or any dealer participating
in the offering will arrange to send you the prospectus and related preliminary prospectus supplement if you request them from RBC Capital
Markets, LLC by calling 1-866-375-6829, UBS Securities LLC by calling 1-888-827-7275, Wells Fargo Securities, LLC by calling 1-800-645-3751
or by emailing wfscustomerservice@wellsfargo.com, and Piper Sandler & Co. by emailing fsg-dcm@psc.com.
EXHIBIT D-1
FORM OF OPINION OF COMPANY COUNSEL
EXHIBIT D-2
FORM OF OPINION OF COMPANY COUNSEL
EXHIBIT E
FORM OF OPINION OF MARYLAND COUNSEL
EXHIBIT F
ISSUER GENERAL USE FREE WRITING PROSPECTUSES
Issuer Free Writing Prospectus dated July 18, 2024 set forth
on Exhibit C hereto.
v3.24.2
Cover
|
Jul. 18, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Jul. 18, 2024
|
Entity File Number |
001-40495
|
Entity Registrant Name |
Angel
Oak Mortgage REIT, Inc.
|
Entity Central Index Key |
0001766478
|
Entity Tax Identification Number |
37-1892154
|
Entity Incorporation, State or Country Code |
MD
|
Entity Address, Address Line One |
3344 Peachtree Road Northeast
|
Entity Address, Address Line Two |
Suite 1725
|
Entity Address, City or Town |
Atlanta
|
Entity Address, State or Province |
GA
|
Entity Address, Postal Zip Code |
30326
|
City Area Code |
404
|
Local Phone Number |
953-4900
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common
stock, $0.01 par value per share
|
Trading Symbol |
AOMR
|
Security Exchange Name |
NYSE
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Angel Oak Mortgage REIT (NYSE:AOMR)
Gráfico Histórico do Ativo
De Jul 2024 até Ago 2024
Angel Oak Mortgage REIT (NYSE:AOMR)
Gráfico Histórico do Ativo
De Ago 2023 até Ago 2024